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During the mitotic mammalian cell cycle cells faithfully replicate their DNA utilizing multiple 
DNA replication sites known as origins of replication. DNA is replicated to provide each 
daughter cell a complete copy of the genome. Replication proceeds bi-directionally from a 
minority of potential origins licensed for replication by a variety of replication factor proteins. 
Replication is catalysed by processive replication enzymes known as DNA polymerases and is 
limited to the synthesis phase (S phase) of the cell cycle. Changes in the timing of replication, 
origin usage and replication rate are indicative of DNA replication stress, a proposed hallmark 
of cancer that causes genome instability. Cell cycle progression is largely controlled by the 
activity of cyclin dependent kinases (CDKs) and their cyclin binding partners. Here using an in 
vitro cell-free DNA replication system we analyse the interplay between Ciz1 and cyclin 
A/CDK2 in regulation of the initiation phase of DNA replication. This demonstrates that Ciz1 
modulates and enhances the activity of cyclin A-CDK2 in cell free DNA replication assays and 
that Ciz1 increases the permissive CDK range that can promote DNA replication.  
Next the inhibitory effect of Ap4A in cell free DNA replication assays is studied. These data 
suggest that Ap4A inhibits initiation by reducing loading of the replicative helicase MCM2-7 
and the DNA polymerase sliding clamp PCNA. These data suggest that Ap4A can inhibit the 
firing of replication origins through disruption of replication complex assembly. Finally, DNA 
combing is established to measure replication parameters. Here we find that the replication 
fork progresses at 1.3kbp/min in mouse fibroblast cells, consistent with other studies, and 
quantify replication fork stalling by replication inhibitor aphidicolin. These data demonstrate 
the potential for cell free DNA replication assays to be combined with DNA combing to dissect 























1.1 Introduction  
Multicellular organisms have evolved multiple overlapping pathways to restrict cell division, 
unless the correct environmental signals are present for growth, or repair of tissues. These 
pathways restrict cellular proliferation in the absence of sustained mitogenic signalling. In 
response to mitogenic signalling cells exit a quiescent state, known as G0, and enter the cell 
cycle (Duronio & Xiong, 2013). Multiple layers of regulation maintain the fidelity of this 
process and therefore control of cellular proliferation. Cancer can be defined as an 
uncontrolled cellular proliferation and arises from multiple mutations that deregulate the cell 
cycle and DNA repair pathways leading to a mutant phenotype and uncontrolled proliferative 
state (Hanahan & Weinberg, 2000). Understanding how cancer arises has important 
implications for its diagnosis, treatment and prevention.  
Cancer is a diverse group of diseases that can be loosely described by the deregulation of the 
cell cycle resulting in the uncontrolled, unrestricted proliferation of cells leading to tumour 
formation resulting in a potentially fatal condition. As life expectancies have increased cancer 
prevalence has also, this has resulted in approximately 8,200,000 cancer deaths worldwide, 
with a predicted 70% increase over the next 20 years (WHO, 2015). Unsurprisingly 
perturbations in each stage of the cell cycle are linked to cancer causing dysregulation, 
emphasising the importance of understanding the regulatory networks that control cellular 
division.  
As cancer is not a single disease, it has to be described through hallmarks originally described 
by Hanahan & Weinberg (2000), the original hallmarks were: sustained growth signalling, 
evasion of anti-growth signalling, resistance to apoptosis, metastasis, cells becoming 
immortalised and angiogenesis. These hallmarks were updated by Hanahan & Weinberg 
(2011) to include: immune evasion, loss of genome stability, inflammation and altering cells 
energy metabolism. These hallmarks provide a framework to study cancer to increase 
treatment and diagnostic options, another common feature of cancers that has been 
proposed to be a hallmark of cancer is DNA replication stress (Macheret & Halazonetis, 2015).  
Replication stress is a feature of cancerous cells. Replication stress is loosely defined as the 
slowing or stalling of replication forks (Macheret & Halazonetis, 2015). Replication stress 
causes unwinding of DNA causing coating in protein RPA through decoupling of replicative 
helicases and polymerases (Ciccia & Elledge, 2010). RPA activates a DNA damage response 
(DDR) causing cells to halt the cell cycle. This allows forks to be restarted, or if damage 
persists, forks collapse and are repaired (Zeman & Cimprich, 2014). Activation of the DDR 
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provides a barrier to tumourigenesis which if bypassed, for example by inactivation of tumour 
suppressor gene p53, can result in incomplete replication, genome instability and 
carcinogenesis (Bartkova et al., 2006).   
Replication stress is induced by multiple mechanisms associated with increased cellular 
proliferation. Increased oncogenic signalling mediated by the mutation of proto-oncogenes 
into oncogenes induces constitutive activation of transcriptional networks that control cellular 
proliferation (Bos, 1989; Nevins, 2001) and increased expression of the cyclin proteins, which 
activate cell cycle promoting cyclin dependent kinases (CDKs) (Keck et al., 2007; Musgrove et 
al., 2011). Both increased oncogenic transcription and increased cyclin-CDK activity DNA 
replication stress, which leads to genome instability further promoting the progression of 
tumorigenesis (Gaillard et al., 2015).  
This project aims to develop techniques that enable investigation of DNA replication stress 
responses to altered CDK activity that is common in cancer. The following sections will explore 
the regulatory mechanisms that control cell cycle progression and timely DNA replication. An 
overview of this process is described and leads into a description of common mechanisms that 
induce DNA replication stress in cancer biology. A better understanding of how these events 
are regulated have important implications for genome stability and prevention of 
tumourigenesis in vivo. 
To gain a better understanding of how deregulated cyclin expression can contribute to DNA 
replication stress, an in vitro DNA replication assay is used. Using an in vitro DNA replication 
system that can precisely titrate cyclin A-CDK2 revealed that there is a narrow permissive 
activity range that can promote DNA replication (Copeland et al., 2010; Coverley et al.). Using 
this approach, the activating concentration of CDK activity can be established and the effects 
of both low and high CDK activity on replication could be monitored in vitro. This approach is 
expanded here to assess how Ciz1 (Reviewed in Section 3.1.2) can enhance, and expand the 
permissive range of cyclin A/CDK2 to promote initiation of replication in a mammalian in vitro 
DNA replication system. This has implications for how increased cyclin-CDK activity could 
contribute to DNA replication stress (Section 1.7).  
In addition, data is presented that suggests that a novel dinucleotide molecule Ap4A 
(reviewed in Section 3.1.3) can block initiation of DNA replication in a mammalian in vitro 
replication system.  Here the inhibitory activity is studied at the level of chromatin association 
of pre-replication complex (preRC) assembly and replisome markers. This approach clearly 
identifies potential for Ap4A to regulate initiation of DNA replication and is consistent with the 
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proposed secondary messenger function in response to genotoxic stress including interstrand 
crosslinks. 
Finally, DNA combing enables high resolution visualisation and quantification of DNA 
replication. DNA combing enables the visualisation of nascent DNA replication forks by 
immunofluorescence microscopy. Here we aim to develop and establish this methodology to 
visualise active DNA replication forks in combination with in vitro DNA replication assays. This 
methodology is used to visualise replication fork progression and monitor fork stalling in 
mouse fibroblasts (Chapter 4). This provides a framework for detailed future analysis of DNA 
replication stress. 
1.2 Regulation of the Cell Cycle by Cyclin Dependent Kinases 
The cell cycle is the co-ordinated series of events a cell undergoes to divide. During this 
process, a cell must ensure that its DNA is replicated accurately and precisely. Across 23 
chromosome pairs, human cells contain around 3 billion base pairs of DNA (genome, 2010). 
Precise regulation of the cell cycle contributes to genomic stability. The eukaryotic cell cycle is 
divided into 4 phases: G1, S, G2 and mitotic (M) phases (Figure 1.1). Separation of the cell 
cycle into these phases ensures faithful unidirectional progression. Failure to precisely 
replicate DNA can result in mismatches and mutations, which can cause abnormal cell 






G1 phase occurs after mitosis in cycling cells, although some cells exit the cell cycle. Cells 
recover from division and begin preparation for DNA replication. Many cells can exit the cell 
cycle at the G1 phase entering G0 phase (Duronio & Xiong, 2013). Some permanently 
differentiated cells enter quiescence and never leave G0 until they are required to replicate 
once more. Cultured mammalian cells will enter G0 in response to nutrient starvation for 
example by serum depletion or contact inhibition (Coverley et al., 2002).  During S phase the 
entire genome is replicated in preparation for segregation during mitosis, a process that 
occurs at multiple sites across the genome, the replication of the genome occurs in roughly 
half an hour in yeast and 9.5 hours in mammalian cells (Brewer et al., 1984; Chagin et al., 
2016). During G2 phase cells prepare for M phase, DNA is checked for mismatches and 
Figure 1.1-The Eukaryotic Cell Cycle. Divided into 4 sections: G1, S phase, G2  and 
mitosis. In G1 cells prepare for DNA replication, in S phase DNA is replicated, in G2 cells 
prepare for the events of mitosis. Mitosis is where chromosome segregate and cells 
divide, mitosis is split into 5 stages: prophase, prometaphase, metaphase, anaphase 
and telophase. Some cells can exit the cell cycle prior to S phase entering quiescence. 
This is known as G0. (Malumbres & Barbacid, 2009; Sullivan, 2007) 
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abnormalities and the mitotic machinery is built. In M phase chromosomes segregate and cells 
divide. (Schafer, 1998) 
Cyclin dependent kinases (CDKs) phosphorylate downstream targets driving the unidirectional 
progression through the cell cycle. CDKs are a family of serine/threonine kinases, without 
dimerization with a cyclin protein they are inactive. Mammalian genomes contain 
approximately 20 CDKs, some have roles in cell cycle progression and some have roles in 
transcriptional regulation (Malumbres, 2014). CDK activity is regulated by dimerization with 
transiently expressed proteins called cyclins , first discovered in sea urchin eggs in 1983 (Evans 
et al. 1983). Cyclins are expressed in a temporally regulated manner; there are many cyclins 
that have roles in cell cycle control, gene expression and transcription (Malumbres, 2014). 
Cyclin binding alone is insufficient for activation of CDKs and requires phosphorylation of the 
regulatory threonine 160 conserved in CDK1, 2, 4 and 6 mediated by the CDK activating kinase 
(CAK) complex of cyclin H, CDK 7 and MAT1. (Lolli & Johnson, 2005). 
There are approximately 30 identified cyclin proteins in the mammalian genome, some having 
roles in cell cycle progression and some in transcriptional regulation (Malumbres, 2014). 
Cyclins A, B, D and E have major roles in the cell cycle and display considerable degeneracy in 
their activity yet are selective in binding of CDK partners (Lee & Sicinski, 2006). Cyclin D 
complexes with CDK 4/6 early during G1 in response to ERK/MAPK signalling from 
extracellular growth signals (Cheng et al., 1998). Cyclin E complexes with CDK2 promoting 
initiation of DNA synthesis i.e. the G1/S transition, cyclin A regulates S phase binding to both 
CDK2 and CDK1 (Donjerkovic & Scott, 2000). Cyclin B regulates mitosis complexed with CDK1. 
(Lim & Kaldis, 2013).  Figure 1.2 shows a schematic for the temporal regulation of cyclin levels 





Precise regulation of cyclin/CDK activity controls progression though the cell cycle and 
contributes to genome stability. Cyclin/CDK activity is controlled by multiple mechanisms that 
ensure activity is calibrated to cell cycle phase. A further level of regulation of CDK activity are 
CDK inhibitor (CDKI) proteins (Yoon et al., 2012). Two CDKIs that are important for regulating 
G1 and restraining entry to S phase are p21Cip1/Waf1 and p27Kip1. p27 and p21 bind to and inhibit 
cyclin E/CDK2 and cyclin A/CDK2 preventing its kinase activity (Abukhdeir & Park, 2008). 
Additionally, p21 protein levels modulates CDK2 activity in cells exiting mitosis promoting 
longer G1 phase when present at high protein levels and shorter G1 phases at low protein 
levels (Spencer et al., 2013).  
A further layer of cyclin regulation and therefore CDK activity is ubiquitin-mediated 
proteolysis. Briefly, proteins can be targeted for proteolysis in proteasomes through the 
addition of multiple chains of the small peptide ubiquitin onto lysine residues through the 
activity of ubiquitin ligase enzymes. Ubiquitination is a multistep process driven by the activity 
of ubiquitin ligase enzymes. First, ubiquitin-activating enzymes (E1) are loaded with ubiquitin 
coupled to ATP hydrolysis, secondly ubiquitin is transferred to a ubiquitin conjugating enzyme 
(E2), finally the ubiquitin protein ligase (E3) brings together target proteins and E2-Ubiquitin 
complexes catalysing the transfer of a ubiquitin moiety to a lysine side chain of the target.  
This is repeated for poly-ubiquitination adding further ubiquitin moieties to the bound 
ubiquitin moiety targeting proteins for destruction in the proteasome. (Berndsen & 
Wolberger, 2014) 
Selection of target proteins for degradation is driven by the E3 ligase enzymes. Ubiquitin 
mediated control of the cell cycle is driven mainly by two families of E3 ligases, the activities 
Figure 1.2-The Temporal Control of Cyclin Levels: The changes in levels of cyclins E (blue), 
A (purple), and B (red) during one round of the eukaryotic cell cycle, dashed lines represent 
barriers between cell cycle phases. (Hochegger et al., 2008)  
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of which differ temporally: These are the anaphase promoting complex (APC/C) and the Skp, 
cullin, F-box containing complex (SCF complex), both complex with different proteins 
modifying ubiquitination targets. The APC/C is activated during anaphase of mitosis until G1 
and the SCF is active during the G1/S transition till the onset of mitosis.  (Teixeira & Reed, 
2013) 
During anaphase the APC/C E3 ligase is activated. Principal targets of APC/C include cyclin B 
and geminin. Proteolytic destruction of these proteins coupled with nuclear membrane 
dissolution mediated dilution creates the low kinase environment that allows for licensing 
proteins such as ORC1 and CDC6 to bind, as well as removing the CDT1 inhibitory protein 
geminin. The activity of the APC/C creates the environment that allows daughter cells to 
prepare for DNA replication again. (Rizzardi & Cook, 2012; Teixeira & Reed, 2013). 
From the start of mitosis through to metaphase APC/C pairs with co-activator CDC20, 
APC/CCDC20 promotes anaphase by targeting proteins such as securin for destruction 
(Nakayama & Nakayama, 2006; Sivakumar et al., 2015). During late mitosis and early G1 
APC/C interacts with CDH1, during this time it targets proteins for degradation. APC/Ccdh1 
targets mitotic cyclin B for degradation, creating the low kinase activity required for G1, but 
also preventing accumulation of cyclins during G1 that could trigger untimely DNA replication 
(Li & Zhang, 2009). In G1, accumulating cyclin E/CDK2 and cyclin A/CDK2 inactivates APC/Ccdh1 
by CDH1 phosphorylation. This is a critical step in the irreversibility of the G1/S transition as 
CDH1 degrades skp2 preventing its accumulation. However, phosphorylation of CDH1 by 
cyclin E/CDK2 and cyclin A/CDK2 promotes degradation via SCFskp2 mediated poly 
ubiquitination. This CDK2 mediated switch of active E3 ligase proteins is one of the major 
events mediating the G1/S transition, powering the oscillation between cell division and DNA 
replication. SCFskp2 activation triggers the proteolytic destruction of CKI such as CKI p27, which 
inhibit cyclin E/CDK2 activity preventing onset of S phase. After destruction of CDH1, cyclin 
E/CDK2 becomes activated phosphorylating pRB promoting more cyclin E expression, creating 
the positive feedback loop that commits cells to S phase. (Giacinti & Giordano, 2006; Rizzardi 
& Cook, 2012; Teixeira & Reed, 2013) 
1.3 Replication Origin Usage 
Compared to mammalian cells bacteria have small genomes, E. coli strain K-12 has a genome 
organised into a single 4.6 million base pair circular chromosome encoding around 4,000 
genes (Blattner et al., 1997). Usually, E. coli can replicate their DNA from a single location on 
the DNA known as an origin of replication termed OriC. OriC is a sequence defined region that 
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is bound by protein DnaA which recruits further proteins that allow unwinding of DNA and 
loading and recruitment of DNA primase, the DNA polymerase III holoenzyme and other 
replication factors (Kaguni, 2011; Robinson & Van Oijen, 2013). DNA replication now proceeds 
bi-directionally from OriC until replication is complete when linked daughter chromosomes 
are separated by topoisomerase IV in a process known as decatenation (Drlica & Zhao, 1997). 
Duplication and separation of the E. coli genome takes roughly an hour, when exposed to the 
right nutrients E. coli can initiate multiple rounds of DNA replication concurrently from 
replicated OriC to allow a rapid doubling time of 20 minutes (Fossum et al., 2007). 
In Eukaryotic systems, multiple linear chromosomes and large genome size require more 
sophisticated mechanisms to ensure timely replication of the genome (Yekezare et al., 2013). 
Eukaryotes replicate their genomes through a complex yet flexible replication programme. 
The budding yeast Saccharomyces cerevisiae has a genome approximately 3 times larger than 
that of E. coli as well as having a much slower replication fork speed (Ranghuraman et al., 
2001). In budding yeasts, replication initiation is determined by a specific sequence of DNA, 
these consensus sequences vary across species, but DNA replication begins at so called 
autonomously replicating sequences (ARS) (Liachko & Dunham, 2014). The Saccharomyces 
cerevisiae genome contains approximately 400 origin sites (Nieduszynski et al., 2006), 
although they are not all used in every round of replication and some origins are used more 
frequently than others (Muller et al., 2014). Use of multiple replication origins in S. cerevisiae 
allow genome replication to occur in approximately 30 minutes (Brewer et al.,1984).  
Mammalian DNA replication origins are more complex, mammalian genomes do not contain 
ARS, instead relying on epigenetic mechanisms to determine origin location. However, GC rich 
sequence elements such as CpG islands are common features (Delgado et al., 1998). Between 
30,000 and 50,000 origins fire in human DNA replication (Leonard & Méchali, 2013). Flexibility 
of mammalian origin usage is high as less than half of the same origins fire in sequential S 
phases (Tuduri et al., 2010). Approximately 10% of origins fire in each cell during replication, 
dormant origins are licensed ready to be used in response to DNA damage or replicative stress 
(McIntosh & Blow, 2012). Suppression of these dormant origins is required to confer 
resistance to DNA fork stalling agents that induce replication stress such as hydroxyurea (Ge 
et al., 2007). Origin usage varies between cells, between tissues and between developmental 
stages, certain changes in the replication programme are observed in cancerous cells (Amiel et 
al., 1998). Replication origins fire asynchronously across the whole genome and can be 
divided into early and late firing replication origins. Origin sites appear to be of high density in 
early firing replicons and lower for late acting replicons (Cayrou et al., 2011). 
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 In budding yeast, S. cerevisiae  firing of an origin at one ARS inhibits the firing of neighbouring 
origins (Brewer & Fangman, 1993) the same is true of mammalian cells (Lebofsky et al., 2006). 
During mammalian S phase, approximately 5,000 replication foci fire to copy DNA at sites 
located close within 3D space through formation of DNA loop structures (Chagin et al., 2016). 
The timing and density of origin usage, coupled with speed of replication fork progression can 
be collectively known as the DNA replication programme. The replication programme ensures 
that the entire eukaryotic genome is replicated in the short window of S phase. This 
replication programme is adapted in response to replication stress, to ensure complete 
genome replication (Ge et al., 2007). Replication stress can be measured by changes in origin 
usage and replication fork velocity changes, one technique commonly used for this is DNA 
combing (reviewed in Section 4.1).  
1.4 Regulation of DNA Replication Initiation 
DNA replication occurs in the S phase of the cell cycle, the G1/S transition is a tightly 
controlled component of the cell cycle. Broadly, DNA replication is composed of three stages: 
initiation, elongation and termination. During initiation sites along the DNA are prepared to 
begin replication, these sites are known as origins, the number of replication origins vary 
across species; from one in some bacteria such as E. coli, to 400 in the budding yeast S. 
cerevisiae to up to 50,000 in the human genome (Leonard and Méchali, 2013; Nieduszynski et 
al., 2006). During elongation, replicative polymerases proceed bi-directionally from origins 
replicating DNA in a semi conservative manner.  
In metazoans, the firing of a replication origin is a tightly controlled multi-stepped process. It 
can be split into 2 phases: replication licensing and replication firing. During replication 
licensing origins are loaded sequentially with a variety of proteins forming a pre-replication 
complex (preRC). Origin licensing occurs from anaphase to G1 of the cell cycle ensuring that 
DNA replication occurs only once per cell cycle. First, origins are bound by the origin 
recognition complex (ORC) (Shackleton and Peltier, 1992). The ORC is a heterohexamer built 
of subunits named ORC 1, 2, 3, 4 5 and 6. The core ORC is made up of ORC2-5 with ORC1 and 
ORC6 binding less strongly. ORC1 binding is an early event in replication regulation (Dhar et 
al., 2001). The ORC then recruits CDC6 and CDT1. The complex of ORC 1-6, CDC6 and CDT1 is 
the PreRC. The PreRC then allows recruitment of the heterohexamer minichromosome 
maintenance complex (MCM) composed of 6 subunits MCM2-7, which promotes recruitment 
of a second MCM2-7 forming a double hexamer of MCM2-7 on chromatin during replication 
licensing (Evrin et al., 2009; Fragkos et al., 2015; Ticau et al., 2015). Figure 1.3 shows the 
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events that occur during replication licensing. Prevention of re-replication is largely driven by 
increased CDK activity (Section 1.5) and ubiquitin mediated proteolysis (Guarino et al., 2011; 
Laman et al., 2001; Méndez et al., 2002; Petersen et al., 1999).  
 
 
Replication licensing and replication origin firing are temporally separated into two distinct 
phases. This is largely driven by CDK activity, after mitogen stimulation of the cell, two kinase 
proteins, cyclin E/CDK2 and DDK, promotes recruitment of CDC45-MCM2-7-GINS complex 
(CMG). The CMG allows separation of the MCM2-7 hexamers activating their helicase activity 
(Takeda & Dutta, 2005). Activation of CMG requires the activity of MCM10 which binds with a 
high efficiency during S phase and a lower efficiency during G1 (Douglas & Diffley, 2016). The 
replicative polymerases are now recruited to these pre-initiation complexes (PreICs), pol α 
synthesises short strands of RNA that primes DNA replication of the leading and lagging strand 
by proccessivity factor PCNA bound pol ε and pol δ respectively (Kelman, 1997). However, 
Figure 1.3-Loading of Pre RC onto a Replciation Origin: The events that occur 
during DNA replication origin licensing. ORC recognises and binds to origins 
recruiting CDC6 and CDT1. Two MCM hexamers are recruited forming an 
inactive pre-RC. (Fragkos et al., 2015) 
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there is emerging evidence that pol δ is required for correct balance of leading and lagging 
strand synthesis and may have an increased role in leading strand synthesis during replication 
stress (Yeeles et al., 2016). 
Interestingly, a minimal framework for eukaryotic DNA replication has been recapitulated in 
vitro using purified yeast replication proteins. This revealed that the basic requirement for 
budding yeast DNA replication initiation, involving 16 replication factors, and cyclin A/CDK2 
and DDK phosphorylation (Yeeles et al., 2015). To achieve replication rates similar to those 
observed in vivo this framework was added to include replisome protein Mrc1 and Csm3/Tof1 
which appeared to stabilise Mrc1 activity (Yeeles et al., 2016).    
1.5 Role of Cyclin/CDKs in Control of Re-replication 
It quickly became apparent that CDK activity was required for the initiation of eukaryotic DNA 
replication. The activity of CDKs also works to prevent relicensing of origins after DNA 
replication has begun, an important mechanism to prevent DNA re-replication.  
The ORC binds DNA independently of CDK activity, however its protein levels are regulated 
indirectly through the activity of CDKs. ORC1 protein is constitutively expressed, and changes 
in ORC1 levels are regulated by ubiquitin mediated proteolysis. (Tatsumi et al., 2003).  ORC1 is 
targeted for degradation after the onset of S phase by the activity of SCFSkp2, the N terminus of 
ORC1 is phosphorylated in multiple sites by cyclin A/CDK2. This phosphorylation leads to an 
increase in nuclear export of ORC1 and targets it for poly-ubiquitination by SCFSkp2 (Laman et 
al., 2001; Méndez et al., 2002). The S phase cyclin A/CDK2 complex prevents the loading of a 
functional PreRC providing a mechanism to prevent re-replication.  
Unlike ORC1, CDC6 activity in mammalian cells is not regulated by ubiquitin mediated 
proteolysis directly following S phase, but through cellular localisation. Prior to DNA 
replication initiation CDKs phosphorylate CDC6 to block its targeted destruction by APC/Ccdh1, 
allowing replication licensing during early G1 (Mailand & Diffley, 2005). During G1 phase CDC6 
accumulate in the nucleus, allowing licensing of DNA (Saha et al., 1998). After the onset of S 
phase when cyclin A levels have accumulated the N terminus of CDC6 becomes 
phosphorylated by cyclin A/CDK2 resulting in the nuclear export of CDC6 (Petersen et al., 
1999). CDK2 phosphorylation again prevents relicensing of DNA replication origins safe 
guarding DNA from re-replication.  CDC6 and CDT1 overexpression has been found in a 
number of human cancers including ovarian and lung cancers (Deng et al., 2016; Karakaidos et 
al., 2004).  
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CDT1 regulation is primarily driven by the activity of geminin. Geminin transcription is 
regulated by E2F transcription factors which are released upon phosphorylation of pRb 
(Yoshida & Inoue, 2004). Geminin is ubiquitinated through the activity of APCCDH1 during 
mitosis, APCCdh1 becomes inactivated after S phase has begun, allowing geminin levels to 
recover during S phase. Geminin binds to and sequesters CDT1 after S phase preventing 
relicensing of origins (Rizzardi & Cook, 2012). CDT1 activity is also regulated by the activity of 
cyclin A/CDK2. Cyclin A/CDK2phosphorylates CDT1, making it a target for poly-ubiquitination 
by SCFSkp2 resulting in degradation of CDT1 in the proteasome. (Liu et al., 2004). Additionally, 
CDT1 contains 2 variant PCNA-interacting peptide (PIP) motifs, once bound to processivity 
factor PCNA CDT1 becomes a target for degradation helping to prevent re-licensing and re-
replication (Guarino et al., 2011).  
Figure 1.4-How CDK Phosphorylation Prevents Re-replication: The activity of CDK2 after the onset of S 
phase promotes the inhibition of the activities of the PreRC proteins CDC6, CDT1 and ORC1. CDK activity 
prevents replication relicensing after DNA replication. (Guarino et al., 2011; Laman et al., 2001; Méndez 
et al., 2002; Petersen et al., 1999) 
Consistent regulation of replication fork proteins displays a pattern in which low kinase 
activities directly following mitosis through the activity of the APC/C result in an environment 
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that facilitates the loading of replication factors (Rizzardi & Cook, 2012). Directly after the 
onset of S phase a high kinase activity driven by the accumulation of cyclin A and E and the 
formation of cyclin A/CDK2 and cyclin E/CDK2 heterodimers results in the targeted 
destruction and re-localisation of early replication factors; figure 1.4 displays ways increased 
CDK2 activity regulates PreRC proteins.   
1.6 CDK Quantitative model of DNA Replication  
The cell cycle of mice fibroblasts can be completed using only the activity of CDK1 to complete 
cell division (Santamaria et al. 2007) suggesting that the various CDK activities display 
functional redundancy. One simple model for the cell cycle suggests that kinase level is the 
key requirement for unidirectional progression through the cell cycle (Figure 1.5)(Hochegger 
et al., 2008). 
 
The quantitative model accurately models intracellular CDK activity in both yeast and 
mammalian model systems. In fission yeast Schizosaccharomyces pombe the mitotic cell cycle 
can be controlled by oscillating the activity of a fusion protein of a yeast cyclin/CDK, revealing 
the kinase activity and two kinase thresholds at S phase and M phase to be the minimal 
framework for the mitotic cell cycle (Coudreuse & Nurse, 2010).   
Figure 1.5-The Quantitative Model of DNA Replication: The increase of kinase 
activity that drives the eukaryotic cell, showing the thresholds required to initiate S 
phase and mitosis and the small window of kinase activity that allows DNA 
replication to occur driving the unidirectional progression of the cell cycle. 
(Coudreuse & Nurse, 2010; Hochegger et al., 2008; Spencer et al., 2013) 
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The mechanisms described earlier on how CDK activity prevents DNA replication re-licensing 
after the onset of S phase creates the upper limit of the kinase level threshold in which DNA 
replication can initiate. This combined with lower kinase limit creates a permissive range of 
kinase concentrations in which DNA replication can occur (Figure 1.5).  During anaphase of 
mitosis the APC/CCDC20 becomes activated resulting in the targeting of cyclins for degradation 
(Teixeira & Reed, 2013).  This results in a reduction of kinase activity within the cell and 
enables protein phosphatases to reduce protein phosphorylation, thereby resetting the cell 
cycle (Wurzenberger & Gerlich, 2011). In this low kinase environment, licensing of replication 
origins can be mediated allowing S phase to occur. 
 In G1 phase cyclin CDK activity is maintained at a low level and accumulates throughout the 
cell cycle peaking in metaphase in early mitosis (Spencer et al., 2013). Within the cell cycle, 
there are two kinase thresholds that must be met for cell cycle progression: The S phase 
threshold and the M phase threshold. As discussed in section  1.5, S phase does not occur at 
low kinase levels that allow replication licensing, the activity of cyclin E/CDK2 and DDK is 
required to transition from replication licensing to the replication origin firing following 
loading of the CMG, PCNA and replicative polymerases (Takeda & Dutta, 2005).   Intracellular 
kinase levels can be visualised using fluorescent sensors that are exported from the nucleus 
when phosphorylated by CDK2, when coupled with measuring S phase entry through 
degradation of fluorescent CDT1 this was elegantly used to demonstrate that S phase entry 
does not occur until after an increase in kinase levels. This defines a low kinase S phase 
threshold (Figure 1.5) (Spencer et al., 2013). 
The high kinase threshold required for mitotic entry can be seen in the classical cell fusion 
experiments by Rao and Johnson (1970). Briefly, DNA replication can be initiated by fusion of 
G1 and S phase phase cells but not when fusing G2 and S phase cells. The high kinase activity 
promotes inhibition of replication licensing factors, such as CDC6, the ORC through 
degradation and re-localisation (Laman et al., 2001; Méndez et al., 2002; Petersen et al., 
1999). Additionally, in budding yeast, at higher kinase levels ORC1 is phosphorylated by CDK 
activity, preventing CDT1 recruitment and inhibiting replication licensing (Chen & Bell, 2011). 
Further additions can be made to the quantitative model if the inhibitory effect of cyclin A-
CDK2 activity that prevents re-replication at high CDK activity is considered. The bifurcated 
response to cyclin A-CDK2 was shown by Coverley et al. (2002) in which an in vitro replication 
system is used to show that mammalian nuclei can be induced to replicate in a G1 extract 
supplemented with cyclin A/CDK2 but only in a tight concentration window, this window 
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represents the permissive range (Figure 1.5). inhibition of S phase entry at low and high kinase 
levels, and the presence of an S phase kinase threshold creates a permissive range of kinase 
activity in which replication origins are licensed and can be initiated surrounded by a lower S 
phase kinase threshold and an upper inhibitory S phase kinase threshold.   
1.7 Mechanisms that Promote DNA Replication Stress 
Mutations cause deregulation of the cell cycle partially through altering cyclin regulation. It is 
important to study the genes that affect this in the search for diagnostic and therapeutic 
tools. It is also important to study the mechanisms by which mutations cause cancer 
development and progression. As cancer progresses genes regulating cell cycle control 
mutate. There are two broad types of genes that mutate in cancer: proto-oncogenes and 
tumour suppressor genes. Proto-oncogenes mutate into oncogenes causing an increase in cell 
proliferation signals (Croce, 2008). An example of this is Ras, which is a signalling protein that 
can become constitutively activated by loss of an intrinsic GTPase activity, this increased cell 
signalling leads to DNA replication stress (Maya-Mendoza et al., 2015). Tumour suppressors, 
however, usually act to restrain cell growth but when mutated lose this function (Sun & Yang, 
2010). Many of the oncogenes and tumour suppressor genes identified interfere with CDK 
activity disrupting regulation of the cell cycle. For example, constitutive activation of mitogen 
signalling leads to cell cycle dysregulation. One prominent example of this is the ERK pathway, 
Activation of this pathway results in cell proliferative signals being activated including the 
expression of cyclin D1 (Filmus et al., 1994). 
Replication stress can be described as the stalling or slowing of replication forks causing a 
change in the normal cellular replication programme. It is an early event in cancer 
progression. Changes in origin usage and replication fork speed can be measure directly by 
visualisation of stretched fibres of DNA in a technique called DNA combing (Reviewed in 
section 4.1). Replication stress is common in cancer development that it has even been 
proposed to be included as a hallmark of cancer itself (Macheret & Halazonetis, 2015).  As an 
important early event in cancer progression it provides a target for the development of 
diagnostics and therapeutics. 
One major source of replication stress in cancer is the activation of oncogenes that induce de-
regulation of the cell cycle. Mutations in signalling pathways that induce constitutive 
activation such as Ras, overexpression of G1 cyclin D or cyclin E or  overexpression of the 
apoptosis inhibitor Bcl2 have been shown to induce DNA replication stress (Maya-Mendoza et 
al., 2015; Jones et al., 2013;Xie et al., 2014). Oncogene activation causes replication stress 
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within the genome. Replication stress causes activation of the DNA damage response 
arresting the cell cycle until DNA can be successfully repaired or cells targeted for apoptosis; 
this provides a barrier to tumorigenesis. Replication stress induces genome instability, further 
mutations in DDR genes such as p53 result in tumorigenesis and cancer progression (Gaillard 
et al., 2015). 
In response to replication stress cells activate the DNA damage response. Replication stress 
causes uncoupling of replicative polymerases and helicases resulting in large stretches of 
ssDNA (Byun et al., 2005). ssDNA becomes coated with RPA (an ssDNA binding protein), that 
facilitates the recruitment of the serine/threonine kinase, ataxia telangiectasia and Rad3 
related protein (ATR) (Ciccia & Elledge, 2010) ATR phosphorylates various proteins, a 
noteworthy target of ATR is checkpoint kinase 1 (Chk1) (Cimprich & Cortez, 2008). Chk1 has 
many functions, a notable one is the phosphorylation of Cdc25. Cdc25 proteins are 
phosphatases that remove inhibitory phosphorylations from CDKs resulting in their activation. 
Chk1 activation causes inhibition of Cdc25 proteins resulting in the inhibition of CDKs and 
arrest of the cell cycle. Cell cycle arrest gives cells time to repair damage done to DNA or if 
necessary enter apoptosis. (Cimprich & Cortez, 2008). Some cancer cells under replicative 
stress rely on the activity of DDR proteins to survive. ATR and CHK1 have been shown to be 
required for cancer cell survival. Inhibition of ATR and CHK1 causes large regions of ssDNA to 
be exposed and replication forks to collapse triggering cell death. The activity of ATR and 
CHK1 is required to stabilise DNA with RPA and prevent replication fork collapse (Sanjiv et al., 
2016). This may provide a novel therapeutic target by inducing unresolvable replication stress 
in cancer cells through inhibition of the DDR.  
Due to the importance of CDKs in both the initiation of DNA synthesis through firing of 
replication forks and prevention of re-replication, it is unsurprising that dysregulation of CDK 
activity leads to abnormal DNA replication and is often dysregulated in cancers. Deregulation 
of CDKs through a diverse range of mechanisms can induce DNA replication stress: 
overexpression of cyclins upregulating CDK activity, changes in cyclin localisation, removal of 
inhibitory phosphorylations. Evidence from multiple cell lines clearly demonstrate that 
mislocalisation or overexpression of cyclin subunits can induce DNA replication stress and 
genomic instability. Cyclin D1 overexpression is found in a variety of cancers including breast 
and lung cancer (Gilett et al., 1994; Gautschi et al., 2007). Cyclin D overexpression is also 
implicated in the development of tumour resistance to radiotherapy (Shimura et al., 2010). 
Cyclin D1 overexpression has been shown to increase double-strand breaks that occur in HeLa 
cells. Cyclin D1 overexpression has been shown through DNA fibre assays to reduce the 
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velocity of replication forks, although this appears to be independent of CDK4 activity 
(Shimura et al., 2013).  
Regulation of Cyclin D1 localisation is also key to cell cycle control. Cyclin D is localised in the 
nucleus during G1 phase and is exported to the cytoplasm during S-phase (Baldin et al., 1993). 
However, if nuclear localisation of cyclin D persists during S phase  re-replication of DNA 
occurs at higher frequency, a feature of replicative stress. This appears to be through 
stabilisation of the PreRC protein CDT1 allowing origins to fire after replication (Aggarwal et 
al., 2007; Vaites et al., 2011). Cancers have been found with cyclin D mutations that prevent 
nuclear export of cyclin D after DNA replication initiation (Benzemo et al., 2006). This shows 
disregulation of the localisation of Cyclin D/CDK 4 during S phase promotes replication stress 
inducing genome instability which could accelerate carcinogenesis. 
Cyclin E overexpression is implicated with cancers such as ovarian cancer (Courjal et al., 1996). 
U2OS cells induced to over express cyclin E activate a DDR detectable through p53 activation 
and CHK1 phosphorylation (Bartkova et al., 2005). DNA combing was used to show that cyclin 
E overexpression caused an increase in replication fork stalling indicating an induction of 
replication stress in cells (Bartkova et al., 2006). Cells overexpressing cyclin E have increased 
numbers of replication origins firing, with reduced replication fork velocity.  Transcriptional 
regulation appears to have a role in cyclin E induced replication stress. Inhibition of 
transcription elongation in cells overexpressing cyclin E partially restores replication fork rate 
closer to wild type cells (Jones et al. 2013). Cyclin E overexpression forces replication with 
insufficient nucleotide levels through premature activation of the RB-E2F pathway, slow fork 
rates can be rescued by supplementation of an exogenous supply of nucleotides. (Bester et 
al., 2011) Deregulation of cyclin E induces replicative stress, implicating CDK activity once 
more. Overexpression of CMG component CDC45 causes replication stress, observed by 
increased origin firing and reduced DNA replication fork speed (Köhler et al., 2016).  
Cyclin A overexpression has been shown to induce phosphorylation of the histone γH2AX in a 
variety of mammalian cell lines in a CDK2 dependent manner (Tane & Chibazakura, 2009). 
γH2AX is a key component of the DDR and indicator of replication stress produced in response 
to DSBs. Furthermore, cells that are deficient in NEK8 show double strand break (DSB) 
formation. NEK8 is involved in the cellular response to DSBs by limiting the activity of cyclin 
A/CDK2 (Choi et al., 2013).  Control of CDK regulation is once more implicated in replicative 
stress and genome instability.  
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Further evidence that CDK activity can induce replication stress comes from studies that 
hyperactivate CDK activity. CDK is inhibited by inhibitory phosphorylations mediated by 
various kinases including Wee1 kinase and PKMYT1 kinase (Abukhdeir et al., 2008). Mutation 
of these sites to produce a deregulated CDK mutant induced genome instability and abhorrent 
mitosis. Furthermore, genetic silencing of the modified form of CDK2 in heterozygous cell lines 
resulted in reduction in the DDR.  Fibre assays showed that loss of inhibitory phosphorylation 
caused a change in the replication programme that results in reduction in replication fork 
speed and increase in origin firing (Hughes et al., 2013). Once again showing that reduction in 
the control of the regulation of CDK activity results in replication stress and genome 
instability.  
Figure 1.6-A Model for Inducing Replication Stress: A pathway by which modifications to CDK 
regulation can induce genomic instability through inducing of replication stress. (Bester et al., 
2011; Hughes et al., 2013; Quereda et al., 2016) 
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The activity of G1 CKIs is also important in maintaining replication stability. As discussed 
earlier p27 and p21 inhibit the activity of CDK2, CDK 4 and CDK6 during G1, preventing the 
phosphorylation of RB, release of E2F transcription factors, inhibiting the G1/S transition. 
Mice have been generated that lack the activity of p27 and p21 and express a CDK4 form 
resistant to inhibition, cells displayed phenotypes typical of increased replication stress. This 
replication stress could be resolved by inhibition of CDK 4 and 6. (Quereda et al., 2016) This 
displays the importance of correct regulation of CDKs during G1 phase to ensure correct 
timely replication.  
Consistently, changes in CDK spatial or temporal regulation, causes changes in the replication 
programme of DNA, causing replication stress and leading to genome instability (Figure 1.6) 
(Zeman & Cimprich, 2014). Critically, phenotypes associated with CDK activity dysregulation 
are found in a variety of cancers (Benzemo et al., 2006; Courjal et al., 1996).  CDK 
disregulation induced replication stress is important to study in the context of cancer 
progression and tumorigenesis.  
 
1.8 Aims  
Here we will establish techniques for studying DNA replication, focusing on CDK activity, 
replication initiation and replication stress. Here in vitro mammalian DNA experiments will be 
used to investigate CDK activity during the events of DNA replication initiation. In vitro 
experiments will also be used to investigate the effect of Ciz1, a cyclin interacting oncogene 
(Reviewed in Section 3.1.3), on CDK mediated initiation. Additionally, in vitro experiments will 
be used to investigate how loading of replication licensing factors MCM2, CDC6, and PCNA is 
affected by Ap4A (Reviewed in 3.1.2), an alarmone produced upon DNA damage. 
 A powerful technique used frequently to measure replication parameters to quantify 
replication stress is DNA combing. Here, this technique will be established with the aim of 
using it to measure if abnormal Ciz1 levels has a role in promoting replication stress. Finally, 
work will be made towards combining in vitro replication experiments with DNA combing to 























2.1 Cell Culture 
NIH3T3 and HeLa cells were cultured using Dulbecco’s modified eagle medium (1 g/l glucose, 
with pyruvate and GlutaMAX I™) (DMEM) (GIBCO) supplemented with 1 % v/v penicillin-
streptomycin-glutamine (100 X) (GIBCO) and 10 % (v/v) foetal bovine serum (FBS) (labtech). 
Cells were grown in 15 cm diameter dishes in 30 ml of media. Cells were incubated in a 
ThermoFisher Scientific HeracellTM 150i, at 37 °C in 5 % CO2.  
Cells were passaged every 2-3 days unless being brought to confluence. Media was discarded 
from cells and cells were rinsed in 10 ml Dulbecco’s PBS (GIBCO), cells were then trypsinsed in 
9 ml DPBS supplemented with 1 ml 0.5% trypsin-EDTA (GIBCO) for 1-2 minutes until cells were 
released from the plates. To protect cells, trypsin was neutralised with an equal volume 
DMEM and split evenly across the desired number of plates and made up to 30 ml with 
DMEM. When trypsinising confluent plates the concentration of trypsin EDTA was doubled 
and incubation was increased to 5 minutes.  
2.2 Cell Synchronisation  
2.2.1 Synchronisation of NIH3T3 by Contact inhibition and Serum Depletion  
NIH3T3 cells were synchronised in G0 through contact inhibition and nutrient depletion. 
Briefly, NIH3T3 cells were grown until they reached confluency, medium removed and 
replaced with fresh growth media and cells incubated for a further 48 hours. Cells were 
released from G0 by trypsinisation and cells replated at 1 in 4 dilution into fresh growth 
medium.  All subsequent timings for synchronised cell populations refer to hours after release 
into fresh media. Figure 2.1 shows a schematic for this synchronisation showing the timeline 
for cells entering S phase. 
 
Figure 2.1 Cell Synchrony Schematic: Schematic for  synchronous release of NIH3T3 cells into S phase from G0 after 
release from G0, displaying the restriction point R and the cells entering S phase as determined previously for this 
methodology (Coverley et al., 2002) 
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2.2.2 Determination of Percentage S-phase Cells by Ethynyl Deoxyuridine Incorporation 
Half an hour before harvesting, cells were pulse labelled with 1 µM EdU (Invitrogen). Cells 
were fluorescently labelled using the protocol outlined in the click-iT® EdU imaging kits 
protocol (Invitrogen). Coverslips were mounted in vectashield with DAPI (Vector 
Laboratories). 
Percentage of cells in S phase was calculated using a Zeiss confocal microscope and counting 
the fraction of DAPI labelled nuclei that had fluorescently labelled replication foci (alexafluor 
555). Only nuclei with replication foci that were present throughout the nuclei were scored 
positive. Percentage of cells in S phase cells was calculated using the equation below. 




2.3 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE)  
Protein fractions were analysed by resuspension of cell fraction at a 1 in 4 ratio 4x SDS PAGE 
loading buffer (200 mM tris HCl pH 6.8, 27.7 mM SDS, 40% (v/v) glycerol, 1 mM DTT) and 
boiled for 10 minutes. Samples were run on 15 well 4–15% ,mini-PROTEAN® TGX™ precast 
protein gels (BioRad) in tris glycine SDS solution (TGS) (250 mM tris, 1.92 M glycine , 1% (w/v) 
SDS) at 200 V for 35 minutes. Gels were analysed by Coomassie staining (2.4) or western 
blotting (2.5).  
2.4 Staining of SDS-PAGE Gels 
Samples were run on an SDS-PAGE, gels were stained using GelCode™ blue safe protein stain 
(ThermoFisher Scientific) using the procedure outlined in its manual. 
2.5 Western Blotting 
Samples were run on SDS-PAGE. Protein was transferred onto an Amersham Protran 0.45 
nitro-cellulose membrane (GE Life Sciences) using a semi dry transfer system. Filter paper, 
nitrocellulose membrane and gels were all soaked in transfer buffer (750 µM trizma base 
(SIGMA), 10 µM CAPS (SIGMA), 0.01% (w/v) SDS, 10% (v/v) ethanol (Fisher)). Four layers of 
filter paper were stacked, followed by the nitrocellulose membrane, gel and then four more 
layers of filter paper. Protein was transferred at 1 mA/cm2 of membrane for two hours.  
Membranes were placed in 10 ml blocking buffer (1% (w/v) BSA (Biowest), 0.05 M tris, 0.138 
M NaCl, 0.0027 M KCl, pH 8.0, 0.1% (v/v) TWEEN 20 (Sigma Aldrich)) for 30 minutes to an 
hour. Membranes were incubated with primary antibody (table 1) for either two hours at 
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room temperature or overnight at 4 °C as indicated. Blots were washed four times for five 
minutes in 5 ml blocking buffer. If primary antibody was HRP conjugated blots were simply 
washed and developed. If unconjugated primary antibodies were used, blots were incubated 
with secondary antibody (Table 1) for one hour. Blots were washed four times for 5 minutes in 
5 ml washing buffer (0.05 M tris, 0.138 M NaCl, 0.0027 M KCl, pH 8.0, 0.1% (v/v) TWEEN 20) 
prior to imaging.  
Blots were developed using the BIO-RAD ChemiDoc™ MP system. HRP conjugated antibodies 




Supplier  Code Dilution Antibody 
Species 
Conjugate  
β-Actin SIGMA A-1978 1/5000 Mouse N/A 
Histone H3 Abcam ab1791 1/10000 Rabbit N/A 
MCM2  BD Biosciences  610700 1/500 Mouse N/A 
CDC6  Santa Cruz 
Biotechnology 
sc-9964 1/500 Mouse  HRP 
PCNA Abcam ab201673 1/500 Mouse HRP 
Mouse IgG Sigma Aldrich A4416 1/5000 Goat HRP 
Rabbit IgG Abcam Ab7051 1/5000 Goat HRP 
Table 2.1-Antibodies Used for Western Blot Analysis 
 
2.6 Standardising Protein Loads 
Protein loads were standardised using actin or histone H3 levels. 10 µl of sample was ran on 
SDS-PAGE and transferred to a nitrocellulose membrane. Membranes were probed for their 
load control and developed. Loading was adjusted across samples to ensure uniform load 
control band intensity.  
Band intensities were quantified using the BIO-RAD image lab software, 1 band was selected 
to be normalised too. The equation below was used to calculate the volume of each sample 
that needed to be loaded to standardise protein loads.  
𝑽𝒐𝒍𝒖𝒎𝒆 𝒐𝒇 𝑺𝒂𝒎𝒑𝒍𝒆 𝒕𝒐 𝑳𝒐𝒂𝒅 𝒊𝒏 𝑵𝒐𝒓𝒎𝒂𝒍𝒊𝒔𝒆𝒅 𝑮𝒆𝒍 (µ𝒍)
=  
𝑰𝒏𝒕𝒆𝒏𝒔𝒊𝒕𝒚 𝒐𝒇 𝑩𝒂𝒏𝒅 𝒕𝒐 𝑵𝒐𝒓𝒎𝒂𝒍𝒊𝒔𝒆 𝒕𝒐 
𝑰𝒏𝒕𝒆𝒔𝒊𝒕𝒚 𝒐𝒇 𝑺𝒂𝒎𝒑𝒍𝒆 𝒃𝒂𝒏𝒅
 × 𝑽𝒐𝒍𝒖𝒎𝒆 𝑳𝒐𝒂𝒅𝒆𝒅 (𝝁𝒍) 
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2.7 Preparation of synchronised Cell-free Materials for in vitro DNA replication assays 
2.7.1 Preparation of synchronised G1 nuclei for cell-free DNA replication assays 
To prepare synchronised cells nuclei 5 plates of NIH3T3 cells were synchronise in G0, and 
released into 20 plates as described in section 2.2.1. After 17.5 hours, cells were harvested. All 
further steps were performed and buffers cooled to 4 °C. Media was removed and cells were 
rinsed in hypotonic buffer (20 mM HEPES (pH 7.8), 0.5 mM MgCl2, 5 mM potassium acetate, 1 
mM DTT), buffer removed, then incubated in hypotonic buffer for 5 minutes. Hypotonic buffer 
was discarded and plates were left at a 45° angle for a further 5 minutes. Excess hypotonic 
buffer was discarded, cells removed from plates by scraping, and cell slurry pooled. Cells were 
lysed using a Wheaton 1 mL dounce homogeniser with seven strokes. Nuclei were removed 
from lysed cells by centrifugation at 6,000 RPM for five minutes at 4OC. The nuclei pellet was 
resuspended in an equal volume of hypotonic buffer, typically around 200 µl of hypotonic 
buffer. Resuspended nuclei were flash frozen directly in liquid nitrogen in 10 µl beads and 
stored in cryovials in liquid nitrogen until use. 
2.7.2 Preparation of Synchronised Soluble Extracts for Cell-Free DNA Replication 
Assays 
G1 phase extract was isolated from NIH3T3 cells synchronised as per section 2.2. After release 
from quiescence, cells were scrape harvested at 15.5 hours, collected in cold 1.5ml 
eppendorfs and dounce homogenised using 20 strokes, nuclei were removed by 
centrifugation at 13,300 RPM for 15 minutes at 4°C. Cell extract supernatant was flash frozen 
in 50 µl beads and stored in cryovials in liquid nitrogen until use.  
2.7.3 Preparation of S-phase Extracts for Cell-free DNA Replication Assays 
HeLa cells were synchronised in S phase using a double thymidine block. HeLa cells were 
cultured in 15cm dishes and passaged until 20 plates were produced at 30-40 % confluence. 
At this point thymidine was added at a 2.5 mM final concentration to growth medium for 24 
hours, cells were washed in 10 ml PBS and replaced with fresh media (-thymidine) for 8 hours 
and a second thymidine incubation (2.5 mM thymidine) for a further 16 hours. Cells were 
released from thymidine block into fresh media and harvested  one hour later. Cells were 
scrape harvested, collected in cold 1.5 ml eppendorfs and dounce homogenised using 20 
strokes, and nuclei were removed by centrifugation at 13,300 RPM for 15 minutes at 4°C. Cell 
extract supernatant was flash frozen in 50 µl beads and stored in cryovials in liquid nitrogen 
until use.   
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2.7.4 Preparation of Polylysine Coated Coverslips 
Round 12 mm diameter coverslips (ThermoFisher Scientific) were dipped in a 1 mg/ml 
solution of poly-l-lysine (Sigma Aldrich), covered to protect from dust and dried overnight. 
Coverslips were stored in falcon tubes at room temperature until use. 
2.7.5 Cell-free Replication Assay 
Cell-free replication assays reaction mixtures added 1:9  nuclei:soluble cell extracts 
supplemented with a premix solution containing an energy regenerating solution, 
deoxynucleotides, biotin-16-dUTP and ribonucleotides Table 2.2 shows the components of 
10x premix solution, Table 2.3 shows the ratios of reagents added to cell cycle specific cell 
extracts. 
Premix  
HEPES pH 7.8 400 mM 
MgCl2 70 mM 
DTT 1 mM 
Phosphocreatine 2 mM 
Adenosine triphosphate (ATP) 30 mM 
Guanosine triphosphate (GTP) 1 mM  
Cytidine triphosphate (CTP) 1 mM 
Uridine triphosphate (UTP) 1 mM 
DeoxyATP (dATP) 1 mM 
DeoxyGTP (dGTP) 1 mM 
DeoxyCTP (dCTP) 1 mM 
Table 2.2-Components of 10x Premix Solution for in vitro Replication Assays 
 
 
Cell-free Replication Assay Reaction Mixture Ratio added to extract 
10 x premix solution 1:10 
0.1 M MgCl2 1:50 
10 µg/ml CPK 1:50 
Biotin-16-dUTP 1:50 
Table 2.3-Reagents Added to Cell Cycle Specific Cell Extracts for Cell-free Reactions 
 
Cell-free DNA replication assays were incubated at 37 °C for half an hour and reactions 
quenched and fixed in 4 % paraformaldehyde (PFA) for 15 minutes at room temperature. 
Poly-l-lysine coated coverslips were added to the bottom of 13 mm diameter scintillation 
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tubes, and 800 µl of 30 % (w/v) sucrose was layered over the coverslips. Fixed nuclei were 
added to the surface of the sucrose solution without breaking the meniscus. Nuclei were 
dense enough to spin through the sucrose cushion by centrifugation at 1500 RPM for 10 
minutes in a Harrier 18/80 centrifuge. The sucrose solution was removed and coverslips 
recovered. Coverslips were transferred to a 24 well plate and washed three times for five 
minutes in PBS.  Coverslips were then washed three times for five minutes in antibody buffer 
(0.02 % (w/v) SDS, 0.1 % (v/v) triton X-100, 0.01 M PBS, 0.138 M NaCl, 0.0027 M KCl, pH 7.4, 1 
% (w/v) BSA).  Coverslips were transferred to a humidity chamber and incubated for half an 
hour in 20 µl of a 1 in a 1000 dilution of streptavidin, Alexa Fluor® 555 Conjugate (Thermo 
Fisher Scientific) in antibody buffer. Coverslips were recovered and washed three times for 
five minutes in antibody buffer, then three times for five minutes in PBS. Coverslips were 
mounted on glass slides with Vectashield antifade mounting medium with DAPI (Vectorlabs). 
Coverslips were visualised using the 40x and 63x magnification of on a Zeiss 810 laser scanning 
confocal microscope. The proportion of positively labelled nuclei was counted by the 
proportion of DAPI stained nuclei with labelled replication foci. The percentage initiation of 
nuclei was calculated using the calculation below.  
% 𝐼𝑛𝑖𝑡𝑖𝑎𝑡𝑖𝑜𝑛 =  
𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑁𝑢𝑐𝑙𝑒𝑖 − 𝐺1 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑁𝑢𝑐𝑙𝑒𝑖
𝑇𝑜𝑡𝑎𝑙 𝑁𝑢𝑐𝑙𝑒𝑖 − 𝐺1 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑁𝑢𝑐𝑙𝑒𝑖
 × 100 
 
 
2.7.6 Western Blot Analysis of Cell-free Replication Reactions  
For western blot analysis 50 µl reactions were prepared. For total protein fractions reactions 
were mixed with 4 x SDS-PAGE loading buffer and boiled for 10 minutes.  
For isolation of the chromatin fraction triton X-100 was added to a final concentration of 0.5% 
(v/v) dissolved in PBS and incubated on ice for 2 minutes. Samples were then centrifuged at 
14000 x g for 5 minutes. Supernatant and pellet were separated, the supernatant was mixed 
with SDS-PAGE loading buffer and boiled for 10 minutes representing the soluble protein 
fraction. The pellet was resuspended in SDS-PAGE loading buffer and boiled for 10 minutes 
representing the DNA bound protein fraction. Samples could then be analysed through SDS-
PAGE and western blot analysis.  
 29 
 
2.8 Bacterial Culture 
2.8.1 Bacterial Transformation  
1 µl of a 50-100 ng/µl plasmid solution was added to 50 µl of competent cell on ice and 
incubated for 30 minutes, bacteria were heat shocked at 42OC for 1 minute and cooled to 4OC 
for 5 minutes. Bacteria were resuspended in 300 µl of super optimal broth with catabolite 
repression (SOC media; 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 10 mM MgSO4, 20 mM glucose; ThermoFisher Scientific) and incubated whilst shaking 
at 37 °C for 1 hour. 100 µl of cultured SOC media was spread onto agar plates and grown 
overnight at 37 °C using suitable selection.  
Transformed bacteria were stored in 50% glycerol. Colonies were picked from agar plates and 
inoculated into 5 ml of LB broth. 500 µl of culture bacteria was added to 500 µl of 50% (v/v) 
glycerol and stored at -80OC. 
2.8.2 Plasmid Purification  
Transformed E. coli were inoculated into 5 ml of LB broth and cultured overnight. Plasmids 
were purified with the GeneJET plasmid miniprep kit (ThermoFisher Scientific) using the 
procedure outlined in the manual. Plasmid concentrations were quantified using the 
ThermoScientific nanodrop 2000c. 
2.8.3 Bacterial Culture  
All culture material was autoclaved before inoculation with bacteria. For normal growth, 
bacteria were grown at 37 °C in 2.5 % (w/v) LB broth (tryptone 10 g/l, yeast Extract 5 g/l, 
sodium chloride 10 g/l) (Melford). Bacterial colonies were cultured on 4 % (w/v) agarose Lb 
agar (Fisher Scientific). When inducing protein expression, bacteria were grown in auto-
induction media (Table 2.4). Auto-induction media contains a low concentration of glucose 
and a high concentration of lactose. Protein expression begins after glucose is metabolised 
switching on expression of lacI regulated genes. This system allows slow expression of 
recombinant protein helping to ensure the expressed protein is soluble. All culture material 






Component Concentration  
(NH4)2SO4 25 mM 
KH2PO4 50 mM 
Na2HPO4 50 mM 
Glycerol 54.3 mM 
Glucose 2.78 mM 
α-Lactose  5.55 mM 
MgSO4 1 mM 
FeCl3 50 µM 
CaCl2 20 µM 
MnCl2 10 µM 
ZnSO4 10 µM 
CoCl2 2 µM 
CuCl2 2 µM 
NiCl2 2 µM 
Na2MoO4 2 µM 
Na2SeO3 2 µM 
H3BO3 2 µM 
Tryptone 1% (w/v) 
Yeast Extract   0.5% (w/v) 
Table 2.4-Components of Bacterial Auto-induction Media 
 
2.8.4 Protein Expression and Purification 
75 ml cultures of BL21 E. coli transformed with pGEX-6P-3 vectors containing genes of interest 
were grown overnight. 75 ml cultures were inoculated into 750 ml auto-induction media 
(Table 2.4). Bacteria were incubated at 20 °C for at least 20 hours post inoculation.  
Bacteria were centrifuged in a Beckman Coulter Avanti J-26 XP centrifuge using a JLA 8.1000 
rotor at 4500 RPM for 15 minutes. Pellets were resuspended in 25 ml HEPES buffered saline 
(HBS) (50 mM HEPES, 135 mM NaCl, 3 mM EDTA, 1 mM DTT, pH 7.8) supplemented with 1 
mM PMSF, and cOmplete™, EDTA-free protease inhibitor cocktail (ROCHE). Bacteria were 
lysed by sonication four times for 15 seconds at 1 minute intervals. Cell lysate was centrifuged 
in a Beckman Coulter Avanti J-26 XP centrifuge using a JA25.50 rotor at 40,000 x g for half an 





0.75 ml glutathione sepharose beads (GE Healthcare Life Sciences) were resuspended in 50 ml 
of HBS per 750 ml culture for 1 hour. Glutathione sepharose beads were centrifuged at 1000 
RPM for 1 minute. Glutathione sepharose beads were resuspended with cell lysate 
supernatant and left to bind on a mechanical wheel at 4OC for one hour. Glutathione 
sepharose beads were centrifuged at 1000 RPM for 1 minute and washed in 10 ml HBS 
supplemented with complete protease inhibitors, this was repeated 4 times. Beads were then 
washed three times by centrifugation and resuspension in 3C buffer (50 mM tris-HCl pH 7.0, 
150 mM NaCl, 2 mM DTT). Beads were resuspended in 1.5 ml of 3C buffer, 10 µl of 
PrecScission 3C protease (GE Healthcare LifeSciences) was added to solution and incubated 
overnight at 4OC on a mechanical wheel. Before addition of 3C protease a sample was taken 
for SDS-PAGE analysis. 
Proteins were eluted using Pierce™ spin columns (ThermoFisher Scientific) using the 
procedure outlined in the manual. Samples were taken from the beads and elution for SDS-
PAGE analysis. Protein samples were flash frozen in liquid nitrogen in 25 µl beads.  
Protein concentration was quantified using the procedure outlined in the reducing agent 














2.9 DNA Combing 
2.9.1 Preparation of Silanized Cover Slips for DNA Combing 
Square 0.5mm thick 22 mm by 22 mm coverslips (Thermo Scientific) were placed in teflon 
coverslip racks. All washing steps take place in fresh, dust free 250 ml beakers. Coverslips 
were briefly rinsed in acetone (Sigma-Aldrich) and air-dried.  Coverslips were washed in 120 
ml 50% (v/v) methanol (Sigma-Aldrich) for 20 minutes in a sonicating water bath.  Coverslips 
were washed in 120ml chloroform (Sigma-Aldrich) for 20 minutes in a sonicating water bath 
and air-dried. 
Piranha solution was prepared by mixing concentrated sulphuric acid (99% w/v) (Sigma-
Aldrich) and hydrogen peroxide (35% w/v) (Sigma-Aldrich) at a 7:3 ratio, adding hydrogen 
peroxide first.  Coverslips were washed in 120 ml of piranha solution in a water bath filled 
from a warm tap for 20 minutes.  
Coverslips were sequentially washed in 120 ml distilled water then chloroform and repeated 
until viscous acid was visibly removed from the coverslips. Coverslips were placed in 120 ml 
heptane (Sigma-Aldrich) with a 1:1000 dilution of (7-octen-1-yl) trimethoxysilane (Sigma-
Aldrich) and left overnight in a desiccator. Coverslips were sequentially washed in 120 ml 
heptane, distilled water, and then chloroform for 5 minutes in a sonicating water bath. 
Coverslips were left to dry then stored individually in 50 ml falcon tubes.  
2.9.2 Pulse Labelling of Cells for DNA Combing 
Pulse labelling was performed on NIH 3T3 cells grown to approximately 70 % confluence in 15 
ml plates. Cells were labelled with iodo-deoxyuridine (IdU) (Sigma-Aldrich), thymidine (Sigma-
Aldrich) and chlorodeoxyuridine (CldU) (Sigma-Aldrich). Cells were pulsed labelled with 25 µM 
IdU supplemented DMEM (section 2.1) with for 20 minutes. Cells were washed with 10 ml 
DPBS then pulse labelled with 30 ml complete DMEM containing 2.5 µM thymidine for 20 
minutes. Cells were washed with 10 ml DPBS then pulse labelled with 30 ml DMEM containing 
250 µM CldU. Cells were washed with 10 ml DPBS then incubated for an hour in 30 ml DMEM 





2.9.3 Purifying Genomic DNA from Pulse Labelled Cells 
Labelled cells were trypsinised, neutralised with 10ml of DMEM and centrifuged at 500 x g for 
5 minutes, pellets were resuspended in 10 ml of PBS. Cells were counted, centrifuged at 500 x 
g for 5 minutes then resuspended. Where possible, cell number was adjusted to 1x107 
cells/ml, if cell number too low cells were resuspended in 330 µl of PBS.  
Cells were warmed to 42 °C. 330 µl of warmed cell suspension was mixed with 195 µl of 42 °C 
melted low melting point agarose (Thermo Scientific) (1 % w/v dissolved in PBS). 100 µl cell 
agarose mixture was added to plug moulds from CHEF genomic DNA plug kit (BIO-RAD) and 
set at 4 °C for 20 minutes. Plugs were added individually to 50 ml falcon tubes containing 250 
µl of 2mg/ml proteinase K in proteinase K buffer from CHEF genomic DNA plug kit (BIO-RAD). 
Plugs were incubated overnight at 42OC. 
Plugs were washed 4 times at room temperature in TNE 50 (10 mM tris-HCl, pH 7.5, 20 mM 
NaCl, 50 mM EDTA) for 1 hour, 1 mM PMSF was included on the third wash. Plugs were rinsed 
in 2 ml of MES-E (50mM MES, 1mM EDTA, pH 5.7) at room temperature for 30 minutes. Plugs 
were incubated in 1.5 ml of MES-E at 65 °C for half an hour then cooled to 42 °C. 100 µl of a 
2% (v/v)  beta agarase I (NEB) in MES-E was added to plugs, which were digested overnight at 
42 °C releasing DNA into solution. 
2.9.4 DNA Combing 
DNA solutions were cooled to room temperature. DNA solutions were poured into milled 
(25x25x4 mm) slots in 100 % teflon blocks. Silanized coverslips were lowered into DNA 
solution and DNA was allowed to bind for 10 minutes. Silanized coverslips were removed from 
wells at a constant speed of 300 µm/sec using a KSV NIMA small dip coater (Biolin Scientific). 
Coverslips were tested for their ability to stretch single DNA molecules. Coverslips were 
combed, glued to slides then mounted directly with 0.1 µM YOYO-1 iodide (ThermoFisher 
Scientfic) in ProLong® diamond antifade mountant (ThermoFisher Scientific).  
For probing labelled DNA coverslips were glued to slides and baked at 60 °C for 1 hour. DNA 
was denatured with 0.5 M NaOH for 30 minutes. Slides were washed three times for three 
minutes in PBS-T (0.01 M phosphate buffered saline, 0.138 M NaCl, 0.0027 M KCl, pH 7.4, 
0.1% (v/v) Tween20), filtered through 0.2 µm filters. Coverslips were blocked with 200 µm of 




Primary antibodies were used to label IdU raised in mouse, CldU raised in rat and ssDNA 
raised in mouse. Anti-IdU primary antibody was detected with a single Alexa Fluor® 633 
conjugated anti mouse IgG secondary antibody raised in goat. Anti-CldU primary antibody was 
detected with an Alexa Fluor® 488 conjugated anti-rat IgG antibody raised in chicken and an 
Alexa Fluor® 488  anti-chicken IgY antibody raised in goat, to intensify the signal. anti ssDNA 
primary antibody was detected using an Alexa Fluor® 568 conjugated anti-mouse IgG raised in 
rabbit and Alexa Fluor® 568 anti-rabbit IgG raised in goat, to intensify the signal (Table 2.5).  
Coverslips were probed with 50 µl primary antibodies for IdU (1/20) and CldU (1/250) (Table 
2.5) dissolved in 1% BSA PBS-T in a humidity chamber for either 2 hours at room temperate or 
overnight at 4 °C. Slides were washed three times for three minutes in PBS-T. Coverslips were 
probed with 50 µl of 1/50 Alexa Fluor® 488 and 1/50 Alexa Fluor® 633 conjugated secondary 
antibodies (Table 2.5) dissolved in 1% BSA PBS-T in a humidity chamber for 30 minutes. 
Coverslips were washed three times for three minutes in PBS-T.  
 Coverslips were probed with 50 µl of a 1/50 dilution of the primary antibody for ssDNA (Table 
2.5) dissolved in 1% BSA PBS-T in a humidity chamber for either 2 hours at room temperate or 
overnight at 4 °C. Slides were washed three times for three minutes in PBS-T. Coverslips were 
probed with 50 µm of Alexa Fluor® 568 conjugated secondary antibodies (Table 2.5) dissolved 
in 1% BSA PBS-T in a humidity chamber for 30 minutes. Coverslips were mounted with 
ProLong® diamond antifade mountant (Thermo Fisher Scientific) and sealed with clear nail 
varnish. DNA was imaged using a Zeiss confocal microscope using the 63 x objective lens. 
Antibody 
Target 
Supplier  Code Dilution Antibody 
Species 
Conjugate 
IdU BD Biosciences  347580 1/20  Mouse N/A 
CldU BioRad OBT0030 1/250 Rat N/A 
ssDNA Merck Millipore  MAB3034 1/50 Mouse  N/A 
Rat IgG Thermo Fisher 
Scientific 
A-21470 1/50 Chicken Alexa Fluor® 488 
Chicken IgY Thermo Fisher 
Scientific 
A-11039 1/50 Goat Alexa Fluor® 488 
Mouse IgG Thermo Fisher 
Scientific 
A-21050 1/50 Goat Alexa Fluor® 633  
Mouse IgG Thermo Fisher 
Scientific 
A-11061 1/50 Rabbit  Alexa Fluor® 568 
Rabbit IgG Thermo Fisher 
Scientific 
A-11036 1/50 Goat Alexa Fluor® 568 















Chapter 3: In vitro analysis of the 
role of Ciz1 and Ap4A in regulation 









3.1 Introduction  
3.1.1 Eukaryotic in vitro Replication Assays 
Initiation of DNA replication at the G1/S transition is a tightly controlled process. Genetic and 
biochemical dissection of this complex process has provided great insight into the regulatory 
events that facilitate precise control of replication origin firing. Eukaryotic DNA replication has 
been studied extensively in yeast and findings have largely been found to be conserved in 
Animalia. Techniques have been developed in which DNA replication can be reconstituted in 
vitro. These in vitro replication experiments have been important for investigating the events 
surrounding the G1/S transition.  
Early experiments using budding yeast S. cerevisiae, and fission yeast S. pombe as model 
organisms to identify both yeast and human CDK and identify their role in cell cycle 
progression. Cdc2 in fission yeast, and cdc28 in budding yeast were identified to be the key 
drivers entering the cell cycle and mitosis (Hartwell, 1971; Nurse & Bissett, 1981). 
Complementation was then used to show that the cdc2 and cdc28 genes were functionally 
homologous to each other, and identified the mammalian homologue CDK1 (Lee & Nurse, 
1987). S. cerevisiae was also used also used to identify the ORC proteins, CDC6, MCM proteins, 
CDC45  (Bell & Stillman, 1992; Piatti et al., 1995; Yan et al., 1991; Zou et al., 1997) . More 
recently budding yeast DNA replication has been recapitulated in vitro. This revealed a 
minimum framework for DNA replication initiation and replication factors required to increase 
fork rate to those observed in vivo (Yeeles et al., 2015; Yeeles et al., 2016)    
Originally cell-free replication experiments were perfomed using cell extracts obtained from 
the eggs of Xenopus species. Xenopus eggs are transcriptionally inactive during their early 
development. Because of this, Xenopus eggs contain many copies of the proteins and 
replication factors required to initiate DNA synthesis. These extracts can stimulate replication 
of Xenopus sperm DNA which can then be used to investigate a variety of factors including 
DNA replication timing and protein loading (Gillespie et al., 2012). Xenopus cell-free DNA 
replication systems are used as a model for higher eukaryotes, cell-free experiments were 
used to show that mitosis is inhibited until DNA replication is completed and showed that 
yeast replication licensing factor homologs ORC proteins, MCM proteins and CDC6 are 
required for higher eukaryotic DNA replication (Dasso et al., 1990; Kubota et al., 1995; 
Romanowski et al., 1996). 
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Mammalian cell-free replication protocols were developed to investigate the events of the 
G1/S transition in the mammalian cell cycle. An early in vitro replication experiment used to 
investigate mammalian DNA replication was the SV40 virus. This virus contains one replication 
origin and uses host cell proteins to replicate, providing a useful model for DNA replication in 
eukaryotes. Human and monkey cell extracts were used to initiate replication (Huwitz et al., 
1990; Waga & Stillman, 1994). SV40 in vitro replication experiments were used to show that 
single strand binding protein RPA was required for DNA synthesis. They were also used to 
show the function of polymerase and primase enzymes on lagging strand synthesis. 
Furthermore, SV40 in vitro experiments were used to investigate the role of PCNA in DNA 
synthesis (Prelich & Stillman, 1988; Tsurimoto et al., 1990; Nasheuer et al., 1992).   
More recently, techniques have been developed in which nuclei can be isolated from 
mammalian cells that can support replication initiation. These are known as replication 
competent nuclei.  A variety of different techniques exist to generate these replication 
competent nuclei. These include isolating nuclei after release from G0 back into the cell cycle 
and chemical arrest of cells at late G1 using metal ion chelator mimosine (Krude, 2006).  
The number of nuclei in S phase can be measured by the incorporation of modified 
nucleotides such a biotin-16-dUTP. Simply, a biotin moiety is added to a uridine nucleotide, 
this can be detected utilizing the interaction between biotin and streptavidin (Coverley et al., 
2002). Streptavidin conjugated antibodies will bind to this nucleotide providing a frame work 
for the immunofluorescent labelling of S phase nuclei. When counterstained with DAPI the 
proportion of nuclei in S phase can be calculated. 
In mouse fibroblasts, quiescence is used to synchronise cells and cytosolic extracts and nuclei 
produced at defined points within G1 phase. Using this approach nuclei are isolated from cells 
after re-entry to the cell cycle following contact inhibition and serum starvation. Nuclei 
isolated after the restriction point but before cells begin to enter S phase are licensed for DNA 
replication and are termed ‘replication competent’ (Coverley et al., 2002). For NIH3T3 cells 
this is approximately 17.5 hours after release from G0.  Nuclei isolated in this way have been 
used to investigate how G1/S phase cyclins A and E function during replication initiation and 
how cyclin A/CDK2 serves to prevent re-replication.  
In vitro replication of replication competent mammalian nuclei provides a valuable tool for 
investigating the events surrounding the G1/S transition and how replication factors and 
replication inhibitors act. This Chapter will use cell-free DNA replication assays to establish the 
protocols and procedures to test the requirements for proteins for the initiation of DNA 
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replication. In addition, we will use this methodology to test the activity of an alarmone 
(Bochner et al., 1984) Ap4A to inhibit the initiation phase of DNA replication and monitor 
replication complex assembly in cell-free replication assays. 
3.1.2 Ciz1 
Cip1 interacting zinc finger protein (Ciz1) is an 898 amino acid, 95 kDa protein. Ciz1 was shown 
to contain an MH3 domain, three zinc finger motifs and two glutamine rich domains (Mitsui et 
al., 1999). It has apparent roles in several cancers including prostate, colon and lung cancer 
(Higgins et al., 2012; Liu et al., 2014; Wang et al., 2014). Ciz1 was first identified by Mitsui et 
al. (1999) using a modified yeast two hybrid system in which recombinant cyclin 
E/p21Cip1/waf 1 was used as bait. Ciz1 cDNA was isolated, cloned and identified as a cip1 
interacting protein.  Warder and Keherly (2003) confirmed that Ciz1 was a nuclear localised 
protein. They used a selection and amplification binding assay to identify a consensus 
sequence to which small nucleotide chains were used to immunoprecipitate with Ciz1. Ciz1 
was found to bind the consensus sequence ARYSR(0–2)YYA. 
Ciz1 was thought to have a role in cell cycle control and oncogenesis due to its ability to bind 
cyclin E interacting proteins. Using cell-free replication experiments it was discovered that 
recombinant Ciz1 could contribute to initiation of replication competent nuclei when 
supplemented into G1 extract containing recombinant cyclin A/CDK2. Ciz1 nuclear localisation 
and interactions with cyclins led to investigation as to its role during DNA replication. Ciz1 has 
been shown to have a role co-ordinating the activity of cyclin A/CDK2 and Cyclin E during the 
early events preceding replication initiation (Copeland et al., 2010).  
 Ciz1 has been proposed to be used in the diagnostics of certain types of cancer. A splice-
variant version of CIZ1 has been shown to be detectable in small volumes of blood that is 
associated with lung cancers, the test has been shown to be highly sensitive, non-intrusive 
and selective. Furthermore, it was demonstrated that reducing the levels of this form of Ciz1 
reduced the growth of tumours, solidifying a direct link between Ciz1 and cancer indicating 
that Ciz1 may act as an oncogene (Higgins et al., 2012) 
Intriguingly Ciz1 has not only been shown to have an oncogenic role but it has also been 
implicated as a tumour suppressor. Nishibe et al. (2013) developed mouse embryonic 
fibroblasts (MEFs) Ciz1 knockouts that displayed increased sensitivity to hydroxyurea 
mediated replication stress and developed leukaemia in response to retroviral infection. It is 
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not unheard of for proteins to act as both tumour suppressor and an oncogene for example 
p21 can function as both through both inhibiting cell growth and apoptosis (Roninson, 2002). 
Ciz1 could act as a kinase sensor, linking together spatial and temporal control of DNA 
replication. Ciz1 has hypophosphorylated and hyperphosphorylated states. In its 
hyperphosphorylated state, it is phosphorylated at threonine 144, 192 and 293. When 
hyperphosphorylated Ciz1 does not interact with cyclin A/CDK2 or promote DNA replication 
initiation (Copeland et al., 2015). This suggests a link between DNA initiation, cellular kinase 
levels and Ciz1. The effects of Ciz1 levels and phosphorylation states on mammalian 
replication should be studied at the DNA replication level to investigate if changes alter the 
replication programme.  
3.1.3 Diadenosine 5 , 5-P1,P4-tetraphosphate (Ap4A) 
Diadenosine 5 , 5-P1,P4-tetraphosphate (Ap4A) is a small alarmone molecule with structural 
similarity to ATP (Pojoga et al., 2004). Ap4A appears to have a role in the cell cycle in a wide 
range of organisms ranging from prokaryotes to eukaroytes (Bambara et al., 1985; Nishimura 
et al., 1997).  Ap4A is found in cells progressing through the cell cycle, but not in cells that 
have exited the cell cycle (Rapaport & Zamecnik, 1976). Basal levels of Ap4A are provided as a 
by-product of transfer RNA (tRNA) synthesis by aminoacyl-tRNA synthetases (Brevet et al., 
1989). 
Ap4A could have an inhibitory role in replication initiation in response to DNA lesions, Ap4A is 
synthesised in cells that have been exposed to a variety of types of DNA damage and in vitro 
experiments have indicated that Ap4A can inhibit replication initiation at cellular levels. 
(Marriott et al., 2015).  
Ap4A metabolism is also implicated in certain cancers. The nudix hydrolase enzyme NUDT2 is 
responsible for the degradation of cellular Ap4A. Marriott et al. (2016) increased Ap4a levels 
by disturbing the NUDT2 gene. When compared with wild type cells, a distinct change in gene 
expression profile was observed, including a reduction in the expression of many cancer 
promoting genes. Whether this is down to increased Ap4A levels or a pleiotropic effect of 
NUDT2 is yet to be seen. However, it provides potential evidence that Ap4A is used by cells to 
control growth in response to DNA damage.  
In this Chapter, we will establish in vitro replication assays from post quiescent NIH3T3 nuclei 
and use them to investigate Ap4A’s effect on replisome assembly, to further investigate the 
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role of Ap4A in restraint of the cell cycle at levels produced in cells in response to DNA 
damage.  
3.1.4 Aims 
To investigate the role of Ciz1 and Ap4A in the regulation of the initiation phase of DNA 
replication. We will use a mammalian cell-free DNA replication system. This chapter outlines 
the principles for preparation of synchronised cell extracts and nuclei to reconstitute DNA 
replication in vitro. Initially, the synchronisation and quality control of reagents will be 
performed. To ensure the quality of reagents, cell-free DNA replication assays will be 
performed in S-phase extract to ensure that materials are competent to initiate. This will be 
followed by reconstitution of initiation by use of recombinant cyclin A-CDK2.  
The in vitro DNA replication system will then be used to analyse the concentration 
dependence of cyclin A-CDK2 for initiation of DNA replication, together with Ciz1 that has 
previously been shown to enhance cyclin A-CDK2 function. Analysis of the role of Ciz1 and 
how it modulates Cyclin A/CDK2 activity will be assessed during in vitro DNA replication 
studies.  
Finally, the role of Ap4A in the inhibition of DNA replication will be determined using cell-free 
DNA replication assays. We will analyse replication protein complex assembly in reactions 





3.2 Generation of Materials for Cell-free Replication Experiments 
3.2.1 Quiescence Release of NIH3T3 Cells   
To ensure NIH3T3 cells could be released from quiescence into S phase to a large enough level 
to be used in cell-free experiments the post-quiescence release technique was tested. Cells 
were released as they would be in cell-free experiments, grown onto coverslips, then pulse 
labelled with EdU. The percentage of nuclei in S phase was scored by incorporation of EdU. 
Figure 3.1 shows a typical result using this type of release.  
Quiescence release experiments showed an increase in the number of cells entering S phase 
between 16 hours and 24 hours after release from G0. This showed the degree by which cells 
could be expected to enter S phase. This demonstrated that the quiescence release technique 
was effective, meaning it could be used for generation of replication competent nuclei. Having 
established the cell cycle kinetics for 3T3 cells facilitates determination of the correct time 
point for harvesting late G1 nuclei. Kinetics may still slightly vary due to temperature changes, 
changes of serum and changes in time at confluence. Consequently, nuclei used 
experimentally are first batch tested to ensure the quality of reagents prior to use.  
 In subsequent experiments, late G1 nuclei are harvested at around 17-17.5 hours where 
typically contains 10-15% of cells are in S-phase. That is monitored as a control in all 
experiments to establish the baseline of initiating nuclei, but there is potential to stimulate 
Figure 3.1-Quiescence Release of NIH3T3 Cells: Release of NIH3T3 cells from quiescence 
into S phase, showing the increase in mean number of cells entering S phase between 16 
and 24 hours (n=3) after release from G0. At each time point >100 nuclei were scored and 
percentage EdU positive cells are shown.  
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this population of nuclei into S-phase by addition of S-phase cell extracts or addition or 
recombinant cyclin A-CDK2 (Coverley et al., 2002; Krude et al., 1997). 
 In addition, G1 extracts were produced by harvesting cells at 15-15.5 hours post-release from 
quiescence. 15 hours is approximately the restriction point of NIH 3T3 cells released in this 
manner (Coverley et al, 2002) This population of cell has approximately 5% of cells in S-phase 
providing a cytosolic extract that is low in CDK activity, and does not stimulate high amounts 
of replication initiation (Copeland et al., 2010). This extract will be used as the negative 
control extract in subsequent replication assays (Coverley et al., 2002; Rahman et al., 2007; 
Copeland et al., 2010). 
3.2.2 Generation of nuclei and extracts for Cell-free DNA replication assays 
Having established that cells can be synchronised (Section 3.2.1) cell cycle specific extracts 
and replication competent nuclei could be isolated for use in in vitro replication experiments. 
Three components needed to be isolated from cells: Replication competent nuclei, harvested 
approximately 17 hours after release; mid G1 cell extract (15hrs post release) (Figure 3.2) and 
S phase cell extract produced in HeLa cells (section 2.7.3 from materials and methods). 
Originally three batches of nuclei were isolated from NIH3T3 cells, each batch was generated 
from synchronising five plates of NIH3T3 cells and releasing them into 20 plates. Nuclei were 
then isolated 17.5 hours after release from G0.  
 
 
Figure 3.2-Timepoints for Harvesting Cell Cycle Specific Extracts and Nuclei: Schematic 
displaying the times at which cell-free components were harvested from NIH3T3 cells after 
release from G0, G1 nuclei were harvested around 17.5 hours (N) and G1 extracts at 









Figure 3.3 – Testing of synchronised populations of nuclei for replication competence 
A) Schematic for reaction mixtures in in vitro replication experiments used to test the 
replication competence of batches of NIH3T3 nuclei harvested 17.5 hours after release 
from quiescence. B) A confocal image of a positively biotin 16 dUTP labelled S phase 
nucleus C) Testing of three batches of nuclei harvested from NIH3T3 cells 17.5 hours 
after release from G0. Nuclei were incubated with G1 and S phase extracts in in vitro 
reactions and the proportion of replicating nuclei in S phase was counted. Data shows 





Each batch of nuclei was tested against G1 and S phase extracts that had previously been 
shown to initiate (S phase extract) and not initiate (G1 extract) DNA replication in replication 
competent nuclei from NIH3T3 Cells. Simply, cell-free reactions were set up where nuclei 
were added to G1 extracts and S phase extracts (Figure 3.3a), and S-phase nuclei determined 
by incorporation of biotin-16-dUTP into nascent DNA during DNA replication. The percentage 
of nuclei with labelled DNA replication foci were scored to determine which nuclei batches 
were replication competent. (Figure 3.3c) 
Figure 3.3b shows the results from the testing of replication competent nuclei. Batches 1 and 
3 were shown to respond as expected to G1 and S phase extracts, the amount of positively 
labelled nuclei increased by a factor of 2.6 and 3.1 between reactions in G1 and S phase 
extract respectively, with a low number of nuclei replicating in G1 extract. Batch 2 showed 
effectively no increase in the proportion of replicating nuclei in response to S phase extract 
compared to G1 extract. This batch was not used in further experiments, any nuclei used in 
future experiments were tested in this manner, only nuclei that increased replication by at 
least a factor of 2 were used. These experiments confirmed that replication competent nuclei 
had been generated, now replication competent cell cycle specific extracts needed to be 
generated and tested.  
Occasionally, like in nuclei batch 2 (Figure 3.3c), nuclei did not initiate in response to a HeLa S 
phase extract. This could be due to differences during the synchronisation process. This could 
be from differences in the degree of confluence during the initial media change, differences in 
the length of time at confluence, quickness of the nuclei harvesting process or simple 
differences between batches of cells.  Hence, all nuclei were quality controlled before use 
experimentally. Titration experiments below were performed using multiple batches of nuclei, 








3.3 Cyclin A/CDK2, Ciz1-N471 and Replication Initiation 
The initiation phase of eukaryotic DNA replication requires the activity of multiple kinases 
including DDK and CDK2 (Yeeles et al., 2015). In mouse fibroblasts, the consensus theory is 
that both cyclin E/CDK2 activity and cyclin A/CDK2 activity are redundant in the activation of 
DNA replication in cycling fibroblasts (Geng et al., 2003; Geng et al., 2007; Kalaszczynska et al., 
2009). However, in nuclei isolated during G1  phase from post- quiescent cells, cyclin E/CDK2 
does not promote initiation of DNA replication (Copeland et al., 2010; Coverley et al., 2002). 
Interestingly, the biochemical reconstitution of DNA replication initiation in S. cerevisiae 
proteins also use human cyclin A/CDK2 to initiate DNA replication (Yeeles et al., 2015).  
3.3.1 Cyclin A/CDK2 Initiates DNA Replication in vitro  
Cyclin A/CDK2 is the cyclin/CDK complex primarily used for the regulation of S phase, cyclin 
A/CDK2 can also initiate DNA replication (Coverley et al., 2002). To investigate the role of 
cyclin A/CDK2 replication initiation in vitro replication assays were used. In vitro replication 
reactions were set up as shown in Figure 3.4. Three types of reaction were prepared, nuclei 
were added to a G1 extract, an S phase extract and further G1 reactions were prepared where 
G1 extract was supplemented with three concentrations of cyclin A CDK2: 0.01 ng/µl, 0.1 
ng/µl and 1 ng/µl. This was to investigate the extent to which different concentrations of 
recombinant cyclin A CDK2 could affect replication initiation. Figure 3.4b shows the 
proportion of nuclei that entered S phase upon addition of varying concentrations of cyclin 
A/CDK2 reaction.  
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These results demonstrate that G1 extract supplemented with 0.1 ng/µl cyclin A/CDK2 can 
cause a small increase in the number of replication competent nuclei. Hela S phase extract 
stimulates a mean initiation of 46.3% of the nuclei used in these experiments. Whereas, G1 
extract stimulated a mean initiation of 13.7% of the nuclei used in these experiments.  Cyclin 
A/CDK2 can promote DNA replication initiation, but not to the extent of a HeLa S phase 
extract. Addition of 0.1 ng/µl Cyclin A/CDK2 yielded a 2-fold increase in S phase population. To 
investigate further the activity of cyclin A/CDK2 a range of concentrations of cyclin A/CDK2 
around 0.1 ng/µl was used (Figure 3.5). 
Reactions were set up as before (Figure 3.4) titrating recombinant cyclin A/CDK2 as before 
using an increased number of cyclin A/CDK2 concentration in the range between 0.01 and 1 
ng/µl. These reactions showed that the optimal replication initiating activity of cyclin A/CDK2 
in G1 extract peaked tightly at 0.1 ng/µl with some increased initiation between 0.08 and 0.12 
A 
B 
Figure 3.4- Cyclin A/CDK2 Promotes Replication Initiation A) A schematic for the cell-free 
reactions performed in this section B) The effects of a varying concentration of cyclin A/CDK2 on 
the mean (N=3) initiation of replication competent nuclei ± standard deviation. 
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ng/µl. Resuming to slightly above base levels of replication at concentrations either side of 
these concentration. This reveals that there is a biphasic concentration dependent activation 
and inhibition of DNA replication. This creates a narrow window of CDK2 activity to promote 
initiation. This inhibitory effect of CDK2 has been associated with the dissociation of 
replication proteins (Chen & Bell, 2011). 
This indicated that cyclin A/CDK2 only initiates replication at a specific concentration that 
defines the activating threshold for CDK activity to promote initiation of DNA replication. 
Furthermore it also identifies the inhibitory concentration of CDK activity to inhibit initiation 
of DNA replication. These data are consistent with the quantitative model of CDK activity 
(Section 1.6). Low and high kinase concentration inhibit DNA replication initiation to ensure 
DNA only replicates at permissible kinase levels during S phase.    
Figure 3.5-Cyclin A/CDK2 Replication Initiation Titration:  The effects of various levels of 
cyclin A/CDK2 supplemented G1 extracts ability to initiate DNA replication in a mammalian in 
vitro replication assay. Data has been normalised using G1 extract and S phase extract 
initiating values. Data is presented as the percentage of nuclei that were initiated out of the 




3.3.2 Purification of Ciz1-N471 
This study uses the DNA replication active Ciz1 N471 construct that retains full activity in DNA 
replication assays but which lacks the C-terminal anchor domain, termed Ciz1 N-471. This Ciz1 
truncation can interact with cyclin E, cyclin A and the replication licensing protein Cdc6 
(Copeland et al., 2010; Copeland et al., 2015). In order to investigate the effects of addition of 
recombinant Ciz1-N471 on the initiation process, GST-Ciz1-N471 was purified by 
immobilisation on glutathione sepharose followed by cleavage with 3C protease to release 
recombinant Ciz1-N471 (Figure 3.6). 
GST-Ciz1-N471 was successfully expressed and bound to glutathione sepharose. Lane 1 shows 
GST-Ciz1-N471 with an approximate molecular weight of approximately 75kDa. This protein 
was digested overnight with 3C prescission protease that released soluble Ciz1-N471, and 
residual GST was retained on the glutathione sepharose beads. Soluble Ciz1-N471 protein 
(lane 3) was found to contain a band at approximately 70 kDa that was previously identified as 
Hsp70 by mass spectrometry (Copeland, unpublished observation). The presence of this 
protein may be related to the predicted native disorder of N-terminus Ciz1.  This is a common 
feature of Ciz1 expression in E. coli but does not affect Ciz1 function in in vitro assays 
(Coverley et al., 2005; Copeland 2010; Copeland 2015).  
Figure 3.6 -Purification of Ciz1-N471 Using a GST Tag: Lane 1 shows the purified recombinant 
protein prior to cleavage of the GST tag. Lane 2 shows the GST tag after cleavage by 3C protease. 




3.3.3 Ciz1-N471 Co-operates with Cyclin A/CDK2 During Replication Initiation  
To investigate the effect of recombinant Ciz1-N471 on recombinant cyclin A/CDK2 initiation 
activity more cell-free reactions were prepared. Ciz1 promotes the activity of cyclin A/CDK2 in 
in vitro DNA replication assays by increasing localisation of cyclin A/CDK2 to chromatin 
(Copeland et al., 2010). The preliminary investigations were initiated to test the effect of Ciz1 
on cyclin A/CDK2 activity in vitro (Figure 3.7). As seen previously, addition of Ciz1 to optimal 
concentrations of cyclin A/CDK2 (determined in Section 3.3.1) increased the proportion of 
nuclei that initiated consistent with its co-operative effect (Figure 3.7).   Ciz1-N471 was 
titrated at increasing concentrations between 0.02 nM and 10 nM into G1 cell-free reactions 
supplemented with 0.1 ng/µl cyclin A/CDK2 (Figure 3.8). Figure 3.7 illustrates the co-operation 
between Ciz1-N471 and cyclin A/CDK2 during replication initiation. In reactions where Ciz1 
was added to G1 extract with no cyclin A/CDK2, no increase in replicating nuclei was observed. 
 
Figure 3.7- Ciz1-N471 Co-operates with Cyclin A/CDK2: The proportion of nuclei that 
initiated DNA replication in in vitro replication assays when reacted in G1 extracts 
supplemented with 0.1 ng/µl cyclin A/CDK2 and 0.1 nM Ciz1-N471 as indicated. S phase 
extract induced a mean initiation of 47.2% in the nuclei used in these experiments. Data is 






These results show that Ciz1-N471 is not sufficient to initiate replication alone, but at 0.1 nM 
Ciz1-N471 promotes cyclin A/CDK2 replication initiation, increasing the replicative capability 
to similar levels as an S phase extract. This is shown by an average initiation of 89% when both 
Ciz1-N471 and cyclin a/CDK2 are present at optimal levels (Figure 3.8). Ciz1 contributes to 
promoting the activity of cyclin A/CDK2 with respect to initiation of DNA replication. This was 
previously related to the ability of Ciz1 to localise cyclin A/CDk2 to chromatin (Copeland et al., 







Figure 3.8- Ciz1-N471 Activity is Concentration Dependent. The effects of various levels of Ciz1-N471 on 
G1 extract supplemented with 0.1 ng/µl cyclin A/CDKs ability to initiate DNA replication in a mammalian 
in vitro replication assay Data has been normalised using G1 extract and S phase extract initiating 
values. Data is presented as the percentage of nuclei that were initiated out of the total that can be 
initiated. N=3 ± Standard Deviation 
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3.3.4 Ciz1-N471 Broadens the Concentrations at which Cyclin A/CDK2 Promotes 
Replication initiation  
To investigate whether Ciz1 influenced the effect of cyclin A/CDK2 activity on initiation of 
replication we have used G1 nuclei and G1 extract supplemented with 0.1 nM Ciz1-N471. The 
activity of cyclin A/CDK2 was assessed between 0.08 ng/µl and 1 ng/µl when co incubated 
with optimal concentration of Ciz1-N471.  Figure 3.9 shows the results of this on the 
proportion of replicating nuclei with and without Ciz1-N471.  
Ciz1-N471 not only seems to contribute to activation of DNA replication through the addition 
of cyclin A/CDK2 but also appears to broaden the range of concentrations at which cyclin 
A/CDK2 can contribute to the initiation of DNA replication over a 10-fold range either side.  
This agonistic and antagonistic interaction with cyclin A/CDK2 activity may play an important 
role in Ciz1s role in cell cycle control as well as its role as an oncogene. This may be important 
for its function observed in a number of cancers, as these perturbations may cause untimely S 
phase entry, which as discussed earlier may induce replicative stress (Pauzaite, et al., 2016).  
 
Figure 3.9- Ciz1-N471 Expands the Range of Concentrations Cyclin A/CDK2 Initiated Replication: The 
effect of G1 extracts supplemented with a range of concentrations of cyclin A/CDK2 on replication 
initiation with and without 0.1nM Ciz1-N471. Data has been normalised using G1 extract and S phase 
extract initiating values. Data is presented as the percentage of nuclei that were initiated out of the 
total that can be initiated. Data displayed as mean (N=2). 
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3.4 Ap4As Role in Replication Initiation  
3.4.1 Ap4A inhibits initiation of DNA replication in S Phase cytosolic Extracts   
Ap4A is induced in response to interstrand crosslinking agents that are commonly used in 
cancer therapy. Cells that are exposed to sub-lethal concentrations of mitomycin C induce 
Ap4A production, with intracellular concentrations reaching up to 20 µM. It has previously 
been demonstrated that 25 µM Ap4A had an inhibitory effect on replication initiation in a cell-
free system (Marriott et al., 2015). Here, the effect of addition of Ap4A on DNA replication 
complex assembly will be determined in cell-free DNA replication assays. First the effect of 
Ap4A was tested using a G1 extract, and an S phase extract in the presence and absence of 
25µM Ap4A (Figure 3.10).  
Figure 3.10- Ap4A Inhibits DNA Replication in vitro: A) Schematic of in vitro replication reactions. B) 
Proportion of initiated nuclei for three reactions:  G1 extracts and nuclei (left) provided the baseline, 
G1 nuclei and S phase extract (middle), G1 nuclei and S phase extract with 24 µM Ap4A. data shows 






Replication initiation was reduced by approximately 65% by addition of Ap4A (Figure 3.10). To 
further investigate the mechanism by which Ap4A prevents the replication initiation of 
replication competent G1 nuclei by a HeLa S phase extract the effects on loading of replication 
licensing and replication factors onto DNA should be investigated.  
3.4.2 Ap4A Prevents S Phase Extract Prevents Loading of Replication Complex Proteins  
To better understand the molecular mechanism by which Ap4A inhibits initiation, western 
blotting was used to visualise the chromatin bound fraction in parallel cell free DNA 
replication assays (Figure 3.11). To investigate the effect of Ap4A on DNA replication, the pre-
RC CDC6 and MCM2 were analysed. This was supported by analysis of the loading of the 
clamp PCNA that is a marker of replisome formation and active DNA replication activity. 
Reactions were performed as in Figure 3.10, the DNA bound protein fraction of the in vitro 
reactions was isolated and probed for replication factors by Western Blot. Figure 3.11 shows 
the effects of 25 µM Ap4A on binding of replication proteins to DNA. 
Data presented in Figure 3.11 is representative of multiple datasets and initiation factors are 
consistent with data from Figure 3.10. These results show that loading of early replication 
Figure 3.11- The Effects of Ap4A on Loading of Replication Protein Assembly: In vitro replication reactions 
were prepared as in Figure 3.10a. A) The chromatin fraction was isolated Western blotted and probed for 






factor CDC6 seemed unaffected by Ap4A. MCM2 is loaded onto DNA later during the 
replication licensing process (Section 1.3), its binding to DNA is impaired when Ap4A is 
included in an S phase extract in an in vitro replication assay. MCM2 binding is reduced but 
not to the level in reactions in a G1 extract. PCNA levels were similarly affected by Ap4A as 
MCM2, levels were reduced but not to the levels of a G1 extract reaction. PCNA associates 
with chromatin during active DNA replication and its levels correlate with the number of 
active replication foci (Chagin et al., 2016). Both reduced MCM2 and PCNA binding correlate 
with the low numbers of replicating nuclei in control reactions and reactions containing Ap4A. 
These data suggest that Ap4A replication initiation inhibition appears to be partially mediated 
by inhibition of licensing that usually occurs when an S phase extract is added to replication 
competent nuclei preventing loading of CMG preventing activation of the DNA helicase 
MCM2-7 and recruitment of the replicative DNA polymerases.  Further analysis of this process 
is required to fully identify the mechanism by which Ap4A blocks initiation of DNA replication. 
However, these data strongly support the data presented by Marriott et al., (2015) 
demonstrating that Ap4A blocks the initiation phase of DNA replication. 
These results have shown that mammalian in vitro replication assays can be a useful tool for 
investigating replication. The effects of replication proteins on replication initiation can be 
seen at fine detail as well allowing analysis of binding of DNA replication factors important 












3.5 Chapter Discussion  
Here in vitro replication experiments have been established as a technique for measuring 
replication parameters. Notably: replication initiation and replisome assembly. 0.1 nM Ciz1-
N471 has been shown to broaden and amplify the replication initiation activity of cyclin 
A/CDK2 (Figure 3.9) marking it as an interesting candidate to study in regards to CDK activity 
deregulation. This capacity to modify nuclei’s response to cyclin A/CDK2 may link Ciz1 to the 
quantitative model of CDK activity (Section 1.6).  
Modified expression of Ciz1 is a common feature in a number of cancers including lung, 
prostate and colon cancer (Higgins et al., 2012; Liu et al., 2015; Wang et al., 2014; Pauzaite et 
al., 2016). However, precisely why cancer cell lines require high Ciz1 levels for tumourigenesis 
is poorly understood. Genetic depletion of a variant of Ciz1 in mice xenograft models restrains 
the growth of tumours (Higgins et al., 2012), indicating Ciz1 has some role in either directly 
promoting tumour growth or facilitating the conditions that allow tumours to survive. These 
data suggests that increased Ciz1 levels may increase the permissive range of CDK2 activity for 
activation of DNA replication initiation. Perhaps, cancer cells require higher Ciz1 levels to 
replicate in the dysregulated CDK environment found in many replication stressed or 
cancerous cells (Section 1.7). A proposed model for this is displayed in Figure 3.12 initiation 
outside the normally permissive zone mediated through Ciz1 may help certain cancerous cells 
continue replicating in a modified kinase background, this may also contribute to a replicative 








Figure 3.12-A Proposed Model for How Ciz1 Could Promote Tumourigenesis: A model that could 
explain how Ciz1 is required for tumour development. In this model, Ciz1 allows cancer cells to 




Data presented here (Figure 3.11) demonstrated that Ap4A inhibits the initiation phase of 
DNA replication and corroborate previous results (Marriott et al., 2015). Here for the first time 
Ap4A has been shown to reduce the amount DNA binding of replication factors PCNA and 
MCM2 to DNA when supplemented in an S phase extract. Ap4A does not affect CDC6 loading 
but it reduces Mcm2 and PCNA loading (Figure 3.11). This could indicate that Ap4A does not 
affect the replication licensing stage of DNA replication, but rather inhibits the loading of the 
CMG, preventing DNA unwinding by MCM2-7, loading of the replicative polymerases and DNA 
initiation. In future, a detailed molecular analysis of the effect of Ap4A on replication fork 
progression could be measured by DNA combing. This approach could investigate active 
replication on single molecules of DNA could provide further insight into how Ap4A affects 
DNA replication. Ap4A has long been proposed to regulate initiation of DNA replication, 
perhaps through the inhibition of DNA pol α (Baxi et al., 1994). The mechanism by which Ap4A 
restrains loading of MCM2 and PCNA is yet to be fully understood but will be vital in 
understanding its role in cell cycle restraint in response to DNA damage. Nevertheless, Ap4A 
has been shown to prevent initiation of DNA replication by blocking replication complex 
















Chapter 4: Investigating 











4.1.1 DNA Combing 
Visualisation of DNA replication at high resolution is possible with DNA combing.  This 
technique enables visualisation of DNA replication to quantitatively determine fork rate, origin 
usage, inter-origin distance (IOD), and fork asymmetry. This is achieved through incorporation 
of modified nucleotides within nascent DNA fibres through pulse labelling of cycling cells. 
Naked DNA is uniformly stretched onto a hydrophobic surface (silanized coverslip) through 
the action of a receding air-water meniscus. DNA can then be fluorescently labelled to 
determine kinetic parameters. This powerful technique can be used to study a variety of 
factors than can measure origin firing and replication kinetics at a high resolution, importantly 
this technique can be used to quantify replicative stress through measurements in changes in 
fork rate and increased fork stalling.  Figure 4.1 illustrates how DNA fibres are uniformly 















Figure 4.1- Molecular DNA Combing: A pH buffered solution of DNA is prepared, 
DNA is bound to a hydrophobic silanized coverslip which is then removed at a 
constant speed. The force applied by the receding air/water meniscus uniformly 
stretches DNA fibres onto the surface of the coverslip. (Labit et al., 2007) 
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This technique was first developed by Bensimon et al. (1994) and greatly increased the 
reliability, reproducibility and the scope of fibre analysis by allowing longer molecules to be 
stretched to a constant 2 kbp:1µm ratio. Due to the inability to perfectly synchronise 
mammalian cells into S phase two different modified nucleotides must be used to investigate 
origin firing. Two commonly used nucleotides are 5-Iodo-2-deoxyuridine (IdU) and 5-Chloro-2-
deoxyuridine (CldU) which can be fluorescently labelled after on slide denaturation of DNA to 
expose epitopes. An antibody sandwiching approach can then be used to intensify labelling, 
aiding visualisation. (Bianco et al.,2012) 
Replication tracks that are duel labelled with both nucleotides can be considered progressing 
replication forks. Replication origins that fire shortly before or during the first pulse labelling 
can also be visualised. Figure 4.2 shows how origins appear depending on when they fire.
       
Ori 
Figure 4.2-Molecular DNA Combing Fibre Schematic. How origins appear depending on the time in 
which they fire in respect to labelling. A) Origin fires shortly before labelling, producing symmetrical  
duel labelled replication tracks separated by an unlabelled region. B) Origin fires during the first 
labelling period producing a single labelled region flanked by the other. C) Origin fires during the 









DNA combing can be used to determine kinetic rates of DNA replication. Replication fork 
velocity can be measured, using the length of the second nucleotide in replication tracks that 
are duel labelled. If tracks are only labelled with one nucleotide, it cannot be certain that 
replication forks were moving at the beginning of the labelling period. The length of this track, 
known pulse labelling period and uniform extension of combed DNA can be used to quantify 
replication fork velocity. Commonly in cells with activated oncogenes replication fork 
progression is slowed, for example cyclin E overexpression and Ras overexpression both 
induce replication stress and replication fork progression is slowed.  (Jones et al., 2013; Maya-
Mendoza et al., 2015)   
Another alteration in the DNA replication programme that occurs when cells are under 
replication stress is replication fork stalling, this will cause activation of the DDR due to 
building up of RPA coated ssDNA (Ciccia & Elledge, 2010). Replication fork stalling rate can be 
measured using DNA combing, by measuring changes in replication track length from 
replication forks originating from the same origin. Briefly; lengths of replication tracks 
progressing bi-directionally from an origin can be measured, if replication forks stall 
frequently the sister replication tracks will be different lengths. This leads to an asymmetric 
extension from a single replication origin (Figure 4.3). The higher the frequency of replication 
fork stalling, the higher the correlation between sister replication track lengths. Fork 
asymmetry has been used to measure replication stress by increased fork stalling rates in 





DNA combing can be used to measure the distance between adjacent origins or inter origin-
distance (IOD). Activation of oncogenes often caused changes in the replication programme 
that result in reduced IOD (Macheret & Halazonetis, 2015). This is possibly a result of 
activation of dormant origins in response to replication stress to ensure complete genome 
duplication (Ge et al., 2007). If IOD is too large, replication may not be completed or cells may 
not be able to compensate for stalled forks (Alver et al., 2014).  IOD is simply measured by 
comparing distances between origins on the same fibre, Figure 4.4 shows a schematic for 
measuring IOD.  
Figure 4.3-Using Replication Fork Asymmetry to Measure DNA Replication Fork Stalling Rate: 
Measuring replication fork stalling rates by comparing asymmetry in sister replication tracks. The lower 
the correlation between sister fork progression the higher the frequency of replication fork stalling. A and 
B display schematics for symmetric and asymmetric origins. C and D display graphs showing a decrease 









Re-replication occurs when control of DNA replication is aberrant and is indicative of 
replication stress, this can be measured using DNA combing. A similar single molecule analysis 
technique called DNA spreading has been used to measure re-replication. Cells are pulsed 
labelled with IdU and CldU with a half hour gap in between. Tracks could then be labelled and 
some regions of DNA were labelled with both nucleotides. This technique was used by Dorn et 
al. (2009) to show overexpression of preRC protein CDT1 and removal of its inhibition induced 
re-replication (Figure 4.5). 
 
Figure 4.4-Quantifying changes in IOD using DNA combing: A schematic displaying changes in IOD 
including increased IOD (middle), and decreased IOD (bottom) 
Figure 4.5-Measuring re-replication using DNA fibre analysis: A schematic for measuring re-
replication. Cells are pulse labelled with IdU and CldU with a half hour gap. Fibres that have no re-
replication have no overlapping (yellow) tracks. Merged image shows a representative image where 




DNA combing provides a way to investigate replication dynamics at high resolution. It can be 
used to measure changes in the replication programme providing powerful insight into how 
cancer changes alter replication programs and induce asymmetry in replication forks. When 
coupled with cell-free replication experiments through synchronisation at the G1/S 
checkpoint it could be used to investigate the effects of Ciz1 levels and phosphorylation on 
DNA replication dynamics.  
4.1.2 Aims 
This chapter aims to establish the techniques required to perform DNA combing. This 
includes: preparation of silanized coverslips and purification of mouse fibroblast DNA. This 
chapter will also establish the pulse labelling and detection techniques required to generate 
duel labelled stretches of mammalian DNA, kinetic data will be generated regarding 
replication fork progression in mouse NIH3T3 cells including: replication fork rate, measuring 
replication fork stalling.  
As a first step towards a detailed analysis of replication origin usage. Initially, the preparation 
of hydrophobic coverslips is discussed, quality control and preliminary work to develop this 
methodology. Stretching of λ phage DNA, dsDNA, ssDNA and analysis of pulse labelled DNA is 
determined. The long term aim is to integrate in vitro DNA replication techniques (Chapter 3) 
with DNA combing to determine effects of increased CDK activity on replication fork 
dynamics. Finally, we aim to integrate synchronised cell-free DNA replication assays (Chapter 
3) with DNA combing. If successful, this would enable careful dissection of replication 
licensing. This approach could be used to study CDK activity on replication fork dynamics, the 








4.2 Preparation of Materials for DNA Combing 
Before replication dynamics of mammalian DNA replication could be measured and 
investigated a variety of materials needed to be prepared and tested: These included 
hydrophobic coverslips for stretching DNA as well as antibodies and verification of the 
combing method.  
4.2.1 Testing of Silanized Coverslips 
First, hydrophobic silanized coverslips were prepared through extensive washing and 
overnight silanization. To ensure coverslips were correctly silanized hydrophobicity was 
tested. This was achieved simply through dropping water on one coverslip, water droplet ran 
straight off demonstrating that coverslips were hydrophobic. Now coverslips could be tested 
for their ability to adhere to DNA and allow stretching once the force from a receding air 
water meniscus was applied. This required optimisation of pH and cell number.  Allemand et 
al. (1997) identified pH 5.5 as the optimum for stretching DNA fibres. However, here pH 5.5 
allowed DNA binding to the hydrophobic coverslip but not stretching. pH was increased 
identifying pH 5.7 as the optimum for stretching DNA fibres. pH 5.7 was used in all subsequent 
experiments.  
To test whether DNA could be successfully stretched onto the surface of the silanized 
coverslips lambda phage DNA was used as a positive control. Lambda DNA was bound to and 
combed onto the surface, slides were mounted with mounting media mixed with YOYO1 
(Figure 4.6). 
Lambda phage DNA was stretched as seen by parallel regions of DNA. Combed lambda phage 
DNA confirmed that the silanization process was successful and allowed for stretching of DNA 
fibres. The process could now be tested on longer genomic mammalian DNA. To ensure that 
DNA from mammalian cell lines could be effectively stretched coverslips were combed with 
NIH 3T3 genomic DNA. NIH3T3 cells were cultured as normal, and grown to approximately 
Figure 4.6 – Combed Lambda Phage DNA: Lambda phage DNA stretched onto a silanized 
coverslip and dsDNA strands stained with YOYO1 (green).  Confocal fluorescence 
microscope image, scale bar= 20 m  
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70% confluence and cells harvested. Naked genomic DNA was purified, combed onto silanized 
coverslips and then probed with YOYO1 to stain dsDNA fibres. (Figure 4.7).   
This was tested using 1 x 107 cells/ml stored in three agarose plugs. In one of the agarose 
plugs, the DNA had degraded during the purification procedure, highlighting the requirement 
to purify DNA separately multiple times from the same sample. 
 Genomic DNA was successfully purified from NIH3T3 cells; Figure 4.7 shows long fibres 
parallel and straight, fibres were stretched in the direction that coverslips were pulled from 
the DNA solution. This confirmed that the cell number being used was acceptable for DNA 
combing, as DNA was not too sparse, nor too close that it formed frequent bundles of DNA.  
Other studies have used 1 x 106 cells/ml of different cell types (Bartkova et al., 2006), however 
1 x 107  cells/ml seemed to generate the sufficient density of DNA for the fibroblasts used 
here.  Having established the correct well density and solution pH for adherence of DNA onto 
silanized coverslips, the denaturation step was performed and ssDNA was detected by 
immunofluorescence. 
4.2.2 Labelling Denatured DNA 
To measure halogenated nucleotide inclusion during DNA replication by DNA combing, 
denaturation of DNA with NaOH is required to expose epitopes on IdU and CldU bases for 
immunofluorescent labelling. As a control to test whether denatured DNA remained stretched 
onto the prepared silanized cover slips an ssDNA antibody was tested. NIH3T3 cells were 
grown to approximately 70% confluence, yielding a 107 cell/ml concentration, harvested and 
genomic DNA purified. DNA was stretched onto the prepared silanized coverslips, dried onto 
Figure 4.7-Combed NIH 3T3 DNA: Confocal Fluorescence microcopy image of Combed 
mouse fibroblast genomic DNA, adhered to a silanized coverslip and stained  with Yoyo1. 
Scale bar = 20 µm 
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the coverslips, then denatured using sodium hydroxide to break the hydrogen bonds between 
strands. Denatured combed DNA was then immunofluorescently labelled using the ssDNA 
antibody as a primary antibody (Figure 4.8).  
 
 
DNA was successfully denatured and remained stretched and intact on silanized coverslips, 
shown by parallel straight lines of DNA (Figure 4.8). DNA was successfully stretched and 
visualised by immunofluorescence.  This allowed testing that halogenated nucleotides could 
be included in growth medium, incorporated into DNA and then visualised on combed DNA 
through immunofluorescence.  
4.2.3 Labelling Replicating DNA 
When labelling DNA for analysis by DNA combing halogenated nucleotides were used. To test 
that halogenated nucleotides could be successfully incorporated into replicating DNA and 
labelled on stretched coverslips NIH3T3 cells were grown and pulse labelled in growth media 
containing IdU for 20 minutes, followed by thymidine for 1 hour to ensure labelled region was 
representative of 20 minutes of replication (Figure 4.9a). DNA was then purified by 
suspending cells in agarose plugs to avoid DNA damaging forces, DNA was combed onto 
silanized coverslips at 300 µm/sec and denatured with NaOH to expose the IdU epitopes. 
Fibres were probed with and anti-IdU antibody and visualised by immunofluorescence (Figure 
4.9).  
Figure 4.8-Detection of ssDNA on Silanized Coverslips. DNA was purified from cycling 
NIH3T3 cells, combed and denatured. DNA was detected with a ssDNA antibody and 





These results are displayed in Figure 4.9. Labelled replication tracks were uniformly stretched 
and aligned with the direction coverslips were removed from the well. DNA was also well 
preserved, of an equivalent length and easily visualised confirming that halogenated 
nucleotides could be incorporated into replicating DNA through inclusion in growth media.  
The combed DNA fibres allow the study of replication dynamics such as replication fork 
velocity and fork stalling experiments. Figure 4.9c displays a single origin that had fired during 
the 20 minute pulse labelling with IdU but after the labelling period had begun. This resulted 
in two adjacent replication tracks of an equal length with a gap in between where DNA was 
replicated before the modified nucleotide was included, this is displayed in the schematic in 
Figure 4.9c. This displayed that this technique could be used for studying the dynamics of 
origin firing, such as using fork asymmetry to measure replication fork stalling rates.  
Single labelling of mammalian cells does not provide sufficient detail to garner much data. 
Without counterstaining of DNA it cannot be known whether adjacent replication tracks are 
on the same fibre. Additionally, it provides no information as to when the DNA in labelled 
replication tracks began replicating. Because of this it cannot be used to generate data 
regarding replication fork speed or information about origins. Because of this duel labelling is 
Figure 4.9-Labelling DNA Replication: Combed genomic DNA purified from NIH3T3 cells labelled with IdU A) 
Schematic representation of the nascent DNA labelling through pulse labelling by addition of IdU for 20 
minutes and addition of excess thymidine to stop labelling. Replication tracks were visualised B) Confocal 
microscope images of immunofluorescence labelled replicating DNA as well as replication origins C) Schematic 





used to give information as to when each track began replicating, if it is a fired origin, a 
termination event or a progressing replication fork.  
4.3 Measuring Replication Parameters  
4.3.1 Duel Labelling of Combed DNA and Estimation of Replication Fork Rate.  
For accurate measurement of replication dynamics by DNA combing such as replication fork 
speed it is required that combed DNA is labelled with 2 modified nucleotides. To measure 
origin firing parameters such as IOD DNA needs to also be probed for ssDNA to ensure that 
adjacent origins fired from the same fibre. To ensure that DNA could be labelled with three 
different antibodies and used for analysis of replication dynamics NIH3T3 cells were grown 
and pulse labelled for 20 minutes with IdU, then thymidine to wash out IdU, then CldU (figure 
4.10a). DNA was then purified, combed and then probed with three different primary 
antibodies. Figure 4.10 displays nascent replicating DNA that could be used for analysis of 
replication dynamics.   
DNA combing can be used to measure replication fork velocity: DNA is uniformly stretched 
and pulse labelled with modified nucleotides for a known length of time. Lengths of 
replication tracks are therefore proportional to a replication fork velocity and can be therefore 
measured in kilobasepairs per minute (kbp/min). Replication tracks that are duel labelled but 
not replication termination events can be considered progressing replication forks. The length 
of tracks representing the second incorporated nucleotide in a duel labelled replication track 
can be used to calculate replication fork velocity. This single fibre data can be expanded to 
include a large number of replication tracks to estimate the average replication fork speed for 
a cell type. This ensemble data provides the distribution of fork rates and enables estimation 






Figure 4.10-Dual labelling mouse fibroblasts with IdU and CldU. A. Experimental overview of the labelling used in 
this experiment B) A duel labelled DNA fibre showing progression of a replication fork. C.) A Duel labelled replication 
origin that fired during the first pulse labelling period. D) A schematic for a replication origin that fired during the 
first pulse labelling as in C. E) A box and whisker plot showing the median replication fork rate, interquartile range 






Figure 4.10b displays a labelled progressing replication fork. Replication was progressing along 
the DNA (blue) from right to left, this is seen by the sequential inclusion of a green track which 
represented the IdU labelling period followed by a gap which represented the thymidine 
labelling period followed by a red replication track which represents the CldU labelling period. 
The replication fork speed could be measured here simply by dividing the length travelled by 
the red replication track by the labelling period. Data from multiple progressing replication 
forks could be used to quantify the replication fork velocity of these cells (Figure 4.10e/f). 
Additionally, previous experiments have identified that DNA combing stretches DNA uniformly 
at 2kbp:1µm (Bensimon et al., 1994). This value can be used to calculate the replication fork 
velocity in kbp/min. 
Figure 4.10c displays a labelled origin that fired during the first IdU pulse-labelling period. DNA 
(blue) began replicating whilst IdU was included in growth medium, replication progressed 
bidirectionally from the centre of the green replication track. The green replication track is 
flanked by two regions of unlabelled DNA (blue) representing the thymidine labelling period 
which are then flanked by two red sister replication tracks which represented the CldU 
labelling period. This showed that origin firing could be visualised by DNA combing. A 
schematic for this is shown in Figure 4.10a.  
Here DNA combing was used to estimate replication fork speed for NIH3T3 cells. DNA was 
pulse labelled sequentially with IdU, thymidine, CldU (figure 4.9a). Only duel labelled 
replication forks on single fibres of DNA flanked by regions of blue DNA, on a constantly 
stretched fibre (Figure 4.10b) were used for estimating replication fork speed.  
Median replication fork rate was 1.31 kbp/min, a rate consistent with other cell types (Table 
4.1). Figure 4.10f shows the distribution of replication fork velocity centralised around the 
median value. Figure 4.10e displays a box and whisper plot of replication fork speed. This 
method could be used to compare replication fork speed between control and experimental 
samples for example cells could be made to overexpress Ciz1 or knockouts developed and 
replication fork velocity could be analysed to investigate Ciz1’s role in DNA replication and if it 





4.3.2 Stalling Replication Forks with Aphidicolin  
Having established that DNA combing could be used to measure DNA replication fork 
progression, to ensure that alterations in fork progression could be detected we used 
aphidicolin to block DNA replication fork progression. Aphidicolin was used to stall replication 
forks by inhibition of DNA polymerases (Baranovskiy et al., 2014). To test the ability of 
aphidicolin to stall DNA replication forks and to determine whether this is measurable through 
DNA combing, NIH3T3 cells were pulse labelled with IdU for 20 minutes, media was replaced 
with thymidine containing media with aphidicolin for 20 minutes, then replacing media with 
CldU and aphidicolin for 20 minutes. This could be compared to a control where aphidicolin 
was not included (Figure 4.11a) if replication fork stalling increased the proportion of 
replication tracks labelled with both nucleotides should decrease. Figure 4.11 displays the 
results of these experiments.  
This provided a positive control to establish that replication fork stalling could be detected. 
Additionally, in the future it could be modified to measure DNA replication fork restart after 
stalling, or the ability to measure stalling of elongating forks rather that initiation when 







Figure 4.11-Observing Replication Fork Stalling Replication fork stalling by treatment with aphidicolin. A 
displays a schematic for the treatment and labelling of cells. B displays replication tracks representative 
of the samples. C displays the proportion of duel labelled replication tracks. (N=2) 
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Figure 4.11a displays a schematic for the treatment of cells before DNA was isolated, combed 
and labelled, experimental samples were treated with aphidicolin to stall replication forks, 
control samples were labelled without inclusion of aphidicolin. Figure 4.11b is a 
representative image of labelled DNA from each of the samples, replication tracks in control 
cells were frequently duel labelled with both nucleotides, whereas cells treated with 
aphidicolin tended to only be labelled with IdU (red) but not the second modified nucleotide 
CldU (green).  Figure 4.11c quantifies the proportion of replication tracks that were duel 
labelled across the aphidicolin treated samples and the control. This showed a reduction in 
the amount of duel labelled tracks. A reduction in duel labelled tracks indicated that at many 
progressing replication forks after treatment by aphidicolin replication fork progression had 
been halted preventing the inclusion of the CldU. This confirmed that aphidicolin mediated 
replication fork stalling could be measured by DNA combing, displaying the usefulness of the 
technique in measuring DNA replication stress.  
4.4 Combing DNA from in vitro Replication Experiments   
As discussed earlier, CDK deregulation induces DNA replication stress (Section 1.7). The results 
described in Chapter 3 demonstrated that in in vitro replication models Ciz1-N471 can both 
broaden and amplify the DNA replication initiation activity of recombinant cyclin A/CDK2 
(Figure 3.7; 3.9). This activity perturbation could constitute CDK activity deregulation if it acts 
the same in vivo allowing cells to enter S phase at canonically non-permissive kinase levels it 
could induce DNA replicative stress.  Combining cell-free DNA replication assays and DNA 
combing by repeating cyclin A/CDK2 titration experiments and investigating the effects of 
replication at non-permissive kinase levels could help identify whether Ciz1 can induce 
replication stress, which could help to explain its apparent oncogenic function. 
Combining cell-free experiments using replication competent nuclei from quiescent release 
synchronised cells could be a powerful tool for investigating replication stress in mammalian 
replication. Replication fork deceleration and replication fork stalling are the definition of 
replication stress (Zeman & Cimprich., 2014). To be able to measure this directly is key in 
identifying factors that induce stress. To test if DNA from nuclei harvested post quiescence 
release cell-free replication assays were prepared as in chapter 3. DNA was purified from 20µl 




DNA combed from in vitro replication assays and stained with YOYO1 consistently resulted in 
short fragmented stretches of DNA, typically shorter than 20 µm, this is displayed in figure 4.8. 
DNA of this quality could not be used for analysis of DNA replication. To successfully use in 
vitro replication experiments in DNA combing the technique will need to be modified to 
ensure that DNA purified is of a high enough quality to get enough data to measure 
replication dynamics. It is not clear why DNA from post quiescent nuclei would produce 
fragmented DNA, this could be due to DNA damage introduced during the nuclei isolation, or 
storage.   
 
4.5 Chapter Discussion   
DNA combing is a powerful tool for the study of DNA replication origin usage, fork rates and 
for investigating replicative stress. Here, the basic steps in establishing the technique were 
completed and a rudimental analysis of DNA fork progression rate determined. In addition, 
measurements of replication fork stalling, and initial attempts to combine post-quiescence in 
vitro replication method and DNA combing.  
We have established DNA combing as a tool for the investigation of DNA replication dynamics 
we can begin to obtain quantitative data to study DNA replication stress in the future. Here 
the replication fork speed of NIH3T3 cells was estimated using DNA combing to be 1.31 
kbp/min. This seems a plausible replication fork speed with other studies providing a fork rate 
between 1-2.1 kbp/min, other replication fork rates seem to vary around this amount. 
Figure 4.12 –Combing DNA from in vitro Replication Experiments: Combed genomic DNA purified from 
nuclei isolated from NIH3T3 cells and stained with YOYO1 (green).  
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Hamster V79 fibroblast cells display a fork speed between around 1.6 kbp/min and 2.1 
kbp/min (Wilhelm et al., 2016) and HeLa cell replication fork speed varies from less than 1 
kbp/min through to 2 kbp/min (Técher et al., 2013). This highlights that this replication fork 
speed is plausible, but also highlights the high variability in replication fork speed even within 
the same cell line, meaning comparing specific fork speed results should only be done within 
experiments, to ensure meaningful results.  
The analysis here has demonstrated that determination of fork progression fits with observed 
rates of other cell lines and species (Table 4.1). The results generated to date suggest that the 
IOD in an unperturbed system has guided few measurable inter-origin distances. DNA fibres 
are   typically too short, and only a few IOD are detected. The technique should be modified to 
yield longer DNA fibres. 
 
The DNA is likely to be sheared after it has been released into buffered solution due to low 
forces applied during movement of the solution. Modification of the procedure can be 
performed in several ways to reduce denaturation of DNA and DNA shearing. These included 
reducing movement between release of DNA from agarose plugs by melting plugs directly into 
the Teflon blocks, altering NaCl concentrations of DNA buffer solution and using a combing 
apparatus with lower friction. Each method saw a large increase in the length of DNA 
visualised by combing (Kaykov et al., 2016).  Modifying the technique could allow for combing 
of longer DNA strands to determine more parameters of replication dynamics. Similar 
approaches can be trialled in the system used in this study to increase fibre length in the 
future. These modifications should also be used when attempting to increase DNA fibre length 
from in vitro DNA replication experiments.   
Once the technique for combing of DNA from post quiescence in vitro replication experiments 
has been developed, it could be used to investigate replication stress in this system. An 
advantage of cell-free replication experiments is that it allows for incorporation of modified 
Species Mean Replication Fork Speed 
(kb/min) 
Reference 
Human Primary Normal 
Keratinocytes 
1.46 (Conti et al., 2007) 
Hamster V-79 Cells 2.09 (Willhelm et al., 2016) 
Saccharomyces cerevisiae  2.9 (median 2.3 (Raghuraman et al., 2001) 
Schizosaccharomyces pombe 2.8  (Heichinger et al., 2006) 
HeLa cells  1-2  ( Técher et al., 2013) 
Table 4.1-Replication Fork Rates of Different Cell Types 
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nucleotides that have large tags such as biotin-16-dUTP and digoxigenin-11-dUTP. This allows 
for detection without denaturation of DNA, by counterstaining dsDNA with Yoyo1, reducing 
the number of antibody incubations, saving time. It would also be of interest to investigate 
replication dynamics in isolated nuclei from mitotically cycling cell compared to post-
quiescent release nuclei.  
There are a number of way nuclei could be duel labelled, Marheineke et al. (2005) duel 
labelled DNA from late G1 nuclei arrested by mimosine using biotin-16-dUTP and digoxygenin-
dUTP and detected using fluorescently tagged avidins for biotin-16-dUTP and using 
fluorescent antibodies to detect digoxygenin dUTP. Another modified nucleotide often used 
to measure DNA replication is EdU; EdU was used in chapter 3 to monitor number of cells 
entering S phase, EdU can be fluorescently labelled using click it chemistry. EdU has been used 
in DNA combing experiments as a substitute for BrdU to avoid the DNA denaturation stage 
(Bianco et al., 2012).  Due to no DNA denaturation being required for any of these detection 
methods DNA can be counterstained with YOYO1 or another fluorescent dsDNA binding 



















5.1 Ciz1 Can Perturb the Replication Initiation Capacity of Recombinant Cyclin A/CDK2  
Results shown earlier display that in in vitro replication assays an N terminal fragment of Ciz1 
can alter the kinetics of DNA replication initiation by recombinant cyclin A/CDK2: both 
increasing the proportion of replication competent nuclei that initiate and expanding the 
range of concentrations that cyclin A/CDK2 can activate DNA replication. This is of particular 
interest for two key reasons:  Ciz1-N471 can expand the replication initiation capacity of cyclin 
A/CDK2, and Ciz1 can modify the replication activating concentrations of cyclin A/CDK2.   
As discussed earlier perturbations in the normal regulation of CDKs during DNA initiation 
often induces replication stress, for example by forcing replication with insufficient nucleotide 
pools (Bester et al., 2011).  Addition of recombinant Ciz1-N471 alters the normal function of 
cyclin/CDK activity during DNA replication initiation at the G1/S transition in in vitro kinase 
experiments. If this is true in intact cells as well as in vitro in nuclei this may provide a 
framework for Ciz1 inducing replicative stress in cells which may help explain its role in a 
number of cancers, including prostate, colon and lung cancer (Higgins et al., 2012; Liu et al., 
2014; Wang et al., 2014). The combination of in vitro DNA replication assays and DNA 
combing could, with refinement, provide a toolkit to investigate whether replication initiation 
at abnormal CDK2 concentrations promotes DNA replication stress. This could help to explain 
whether Ciz1 has a direct role in inducing replication stress and whether or not this underpins 
its apparent oncogenic activity.  
Another reason is that DNA replication initiation in non-cancerous cells does not occur at the 
higher kinase levels found in the latter stages of the cell cycle, orchestrated through a variety 
of mechanisms discussed earlier, for example activation of ubiquitination of replication 
licensing proteins through cyclin/CDK activity (Laman et al., 2001; Méndez et al., 2002). 
Cancer cells have mutations that increase the basal kinase levels of cells for example cyclin D 
and E overexpression. Ciz1 could serve as an adapter protein allowing replication to occur at 
non-permissible kinase levels in cancer cells, this could explain its increased expression in 
certain tumour types, and cancer cells that display an overexpression of ciz1 could be 
displaying gene addiction to Ciz1 to allow continued replication. 
If Ciz1 is inducing replication stress or facilitating replication through gene addiction in 
abnormal kinase conditions (Figure 3.12), then it could be a useful target for the development 
of future therapeutics and diagnostic tools against certain cancer types.  
 80 
 
5.2 Ap4A Blocks Replisome Assembly 
Results gathered here have demonstrated that Ap4A reduces the fraction of replication 
competent nuclei that can be initiated to replicate their DNA by an S phase extract.  
Additionally, replication licensing proteins and replication protein binding were shown to be 
reduced when Ap4A was included in a HeLa S phase extract. Ap4A appears to prevent DNA 
replication initiation by blocking the replication licensing process, thereby preventing the 
formation of preRCs, pre ICs and binding of PCNA. Ap4A may function through binding of the 
DNA primase enzyme DNA pol α (Baxi et al, 1994). If Ap4A inhibits DNA pol α it may act in a 
similar manner to aphidicolin which inhibits polymerase activity resulting in stalled replication 
forks (Krokan et al., 1981). If this is the case prevention of replication complex assembly could 
be mediated through replication fork collapse after sustained lack of replication initiation. 
Replication assays chould be set up utilizing aphidicolin to compare whether aphidicolin 
prevents replisome assembly in the same manner as Ap4A. 
The effect of aphidicolin on already elongating replication forks would be interesting to 
investigate. Data obtained thus far does not provide insight into whether Ap4A prevents just 
initiation, or elongation. This could be studied by combining in vitro replication assays with 
DNA combing. Nuclei could be initiated with an S phase extract with Biotin-16-dUTP followed 
by centrifugation and extracts replaced with an S phase extract containing Ap4A and EdU. 
Data could be obtained from parallel reactions of both replisome assembly, through western 
blotting, and replication fork progression data, through DNA combing.  
Ap4A has previously been shown to bind ATP binding domains as it has a structure similar to 
ATP (Maness et al., 1983). Ap4A could be competing with ATP for a number of proteins 
involved in the loading of the proteins here to DNA. PCNA is loaded onto DNA by replication 
factor C (RFC) a AAA ATPase (Thompson et al., 2012). PCNA binding is consistently blocked by 
Ap4A in the experiments shown here. This could be due to Ap4A blocking ATP binding to RFC.  
MCM2 DNA binding is shown to be reduced in in vitro replication experiments in a manner 
that varies highly between nuclei batches. MCM2 is part of the heterohexameric MCM2-7 ring 
that binds DNA. MCM2-7 like PCNA binds DNA as a ring and requires ATP activity to assemble 
and encapsulate the DNA fibres and mediate interactions with DNA polymerases (Kang et al., 
2014).  If Ap4A is mediating its effect as an ATP competitive inhibitor it is possible that MCM2-
7 DNA binding could be blocked by Ap4A competing for ATP binding.  Similarly Ap4a may 
inhibit kinases in a similar manner which could prevent loading of the CMG, prevent 
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polymerase recruitment and PCNA loading. Preliminary work appeared to show that Ap4A 
could inhibit TAK1, but further analysis has cast doubt on this observation. 
Ap4a is produced by cells in response to the DNA damaging agent mitomycin C (Marriott et 
al., 2015). Ap4A could form part of a response in cells to DNA damage that allows cells to 
prevent cell cycle progression allowing damaged DNA to be repaired to prevent generation of 
mutations and abnormal chromosome structures. This could be due to changes in gene 
expression, like those seen when NUDT2 expression is impaired (Marriott et al., 2016), which 
leads to down regulation of certain cancer promoting genes. Or this could be due to the direct 
activity of Ap4A. Figure 5.1 shows a schematic for a potential replication inhibitory pathway 
for Ap4a. The unknown mechanisms by which Ap4a prevents DNA replication in in vitro should 
be investigated further and it should be identified whether this is a novel pathway or whether 













Figure 5.1-Model for Ap4A Replication Initiation Inhibition: Proposed timeline for Ap4A 
production to prevent DNA replication in response to DNA damaging agents. Highlighting 
the unknown mechanism for ATP blockage of replication.  
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5.3 DNA Combing 
DNA Combing has been established here as a technique for measuring replication dynamics in 
mammalian cells to gain greater insight into the DNA replication programme in mammalian 
cells. Replication parameters were shown to be measurable and quantifiable using DNA 
combing including DNA fibre length, replication fork speed and replication fork stalling. Going 
forward these techniques will be useful in determining whether the oncogenic capacity of Ciz1 
is through an abnormal Ciz1 activity inducing replication stress or abnormal DNA replication 
and to visualise DNA replication forks in Ap4A inhibited cells to gain greater insight into this 
process. 
The major problem with DNA combing seen here was short DNA fragment lengths found in 
cell free experiments. Solutions to this problem were discussed earlier (Section 4.5). Another 
issue discovered with combing was inconsistency in the silanisation of coverslips sometimes 
leading to non-stretched DNA (occurring in around 1 out of 4 coverslips). This was resolved by 
stretching samples of DNA onto multiple coverslips to ensure that data could be obtained, this 
is fairly resource costly as the time and reagents that are required for generation of small 
numbers of silanized coverslips is high, making it essential to optimise the procedure as best 
as possible.  
Inspection of coverslips during the cleaning and silanisation stages of the coverslips can be 
done to ensure sufficient drying of coverslips, no decolouration or debris build up and viscous 
acid is removed sufficiently. If a powder like build up appears on coverslips they must be 
discarded. The hydrophobicity of coverslips can be tested by dropping water onto coverslips, 
if coverslips are coated water will run straight off. Coverslips used for experiments could be 
tested by dropping water onto one side of the coverslip and combing DNA onto the other. 
Another solution to this issue that is discussed later (Section 5.3) is DNA spreading, a single 
fibre analysis technique that does not require the production of silanized coverslips.  
5.4 DNA Combing replicability and accuracy 
Whilst DNA combing can be used to measure the IOD of origins that fired during the first of 
two sequential halogenated nucleotide pulse labelling this likely undervalues the real IOD. 
This is due to origins that fire before, after the first pulse labelling or multiple neighbouring 
origins being masked when firing within the same labelling stage. (Técher et al., 2013) This 
means that the overall IOD cannot be concluded from DNA combing but an IOD 
representative of the labelling timeframe. However, changes to the overall IOD would cause 
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changes to the representative IOD so significant changes in IOD observed by DNA combing as 
an experimental response still provide useful information as to whether or not replication 
stress is being induced.  
Variability in replication dynamics between different batches of cells could lead to false 
results. The same cell lines have observed different replication fork speeds on multiple 
occasions between studies (Técher et al, 2013). This could be due to different culture 
techniques in different labs. Due to these differences seen by others, it is essential to treat 
cells used in experiments in exactly the same manner for as long as possible before testing 
experimentally. For example, if an experiment was being designed in which a drugs effect on 
replication fork speed on an asynchronous culture of cells was being tested cells must be 
treated identically up to the point of the drug treatment. This would include reviving cells 
from the same stock, using the same media and serum during cell growth, and pooling 
trypsinised cells during any passages before splitting across multiple plates. These would 
reduce any artificial differences in replication dynamics created by differences in preparation 
leading to a more accurate experimental result.   
To add further validity to DNA combing results, further methods of DNA stretching could be 
used. A prominently used alternative to DNA combing to stretch single DNA fibres is DNA 
spreading. DNA spreading was first used to map to hamster dihydrofolate reductase gene 
locus (Parra & Windle, 1993).  DNA spreading is a technique in which cells are dropped onto 
slides, dried and lysed directly onto the slide surface. Slides are then tilted at a 15° angle along 
the X axis allowing the DNA to run down the slide and stretch, where it can be fixed and 
labelled (Jackson & Pombo, 1998).  
DNA spreading has been since adapted to measure replication fork speed, by pulse labelling 
growing cells with IdU and CldU and detected in the same manner as used for DNA combing 
single fibre experiments. DNA spreading has been used to show that Fanconi anaemia 
proteins help protect forks halted by treatment with hydroxyurea through IdU incorporation, 
expanding their DNA repair role across further forms of DNA damage than interstrand 
crosslink repair. (Schlacher et al., 2012)     
Obtaining results of replication dynamic parameters through both DNA spreading and DNA 
combing will identify any differences between the two DNA stretching methods and could 
provide further validity to any results gained using one of the methods. DNA spreading uses a 
smaller cell number than DNA combing; using 2 µl drops of a cell suspension in the 105 
cells/ml range, depending on cell type (Nieminuszczy et al., 2016). This would equate to DNA 
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harvested from 200-2000 cells on each slide. DNA harvested from 330 µl of 1 x 107 cells/ml in 
the DNA combing method described here represents DNA from approximately 3.3 x 106 cells. 
It would be interesting to see if harvesting DNA from a smaller sample of cells introduces 
biases or differences when compared to the larger number used in DNA combing.  
5.5 Future Techniques for Measuring Replication Parameters 
DNA sequencing technology has advanced rapidly since the human genome was first 
sequenced by the year 2000 (Lander et al., 2001). Whilst the sequencing of the first genome 
took decades of international collaboration next generation sequencing technology has 
drastically cut the cost and time required for sequencing of long strands of DNA meaning that 
a human genome can now be fully sequenced for as little as $1,000 (Goodwin et al., 2016). 
Advances in DNA sequencing have long term benefits on personalised medicine and  disease 
causing SNP analysis it could also be very useful for the study of DNA replication.  
One of the most interesting developments in DNA sequencing is nanopore sequencing. The 
basis of nanopore sequencing is that DNA will cross a membrane due to an electrochemical 
gradient because of DNA’s negative charge. As DNA crosses pore it produces a change in 
electrical signal that is different for each DNA. Nanopore sequencing has been miniaturised by 
Oxford Nanopore Technologies, DNA is fed through a protein pore by a processive helicase 
enzyme with a known DNA feed rate allowing for high throughput real time DNA sequencing  
(Eisenstein, 2012; Feng et al., 2015).  This technique can be used to recognise modified 
nucleotides. For example, polymer tagged nucleotides have been developed that have a 
distinct signal from normal nucleotides (Fuller et al., 2016). Using modified nucleotides pulse 
labelled into growing cells it could be theoretically possible to measure DNA replication at the 
sequence level to provide high fidelity information regarding replication parameters at both 
the length and sequence level.  
Deep sequencing techniques have been used to generate maps of origin usage frequency in 
yeast (Müller et al., 2013). Briefly, DNA copy number was sequenced and compared across S 
phase and G1 phase yeast cells. The higher the copy number showed increased origin usage. 
This technique was used to compare origin usage across diploid and haploid yeast. This 
technique would be more difficult to measure origin usage in mammalian populations due to 




5.6 Methods for Obtaining More Consistent Cell Synchrony for in vitro Replication Assays 
Budding and fission yeast cultures can be released into S phase by arresting in G1 to a much 
greater extent to mammalian cells. This means combing experiments can be achieved using 
only one modified nucleotide as it can be known when they initiated (Lebofsky & Bensimon, 
2003). Sadly, this is not true for mammalian cells that require duel-labelling experiments to 
accurate determine replication kinetics.   
Mammalian cell culture synchronization is not as simple. The methods used here provide 
approximately 45% release into S phase. However, there are inconsistencies in S phase entry 
between batches of nuclei. This can be caused by different times in reaching confluency, 
different incubation periods or simple cell to cell variability. These two factors highlight a need 
for more methods for synchronising mammalian cell populations. Using a synchronised cell 
population may help to enrich for replicating DNA in DNA combing; increasing the number of 
cells in S phase and therefore the number of labelled fibres. This may introduce certain biases 
though as the kinetics of DNA replication may be different at the start or end.   
Another method that can be used to isolate cell cycle specific cell populations is through 
centrifugal elutriation. Centrifugal elutriation separates particles based on their size and can 
be used to differentiate between cell cycle stages.  Different fractions can be isolated and 
analysed by flow cytometry to determine their cell cycle stage (Banfali, 2011).   
Isolation of a population of late G1 nuclei through centrifugal elutriation followed by dounce 
homogenisation may provide a better signal to noise ratio in S phase extract initiation and 
more consistent protein loading results, as their flow cytometry profiles would always be 
verified. Additionally, consistency between nuclei isolated through centrifugal elutriation, and 
contact inhibition/serum depletion would help to confirm results. As well as potential 
identifying differences between mitotic cell cycle and cells re-entering the cell cycle from 
quiescence. Interestingly comparing nuclei harvested in the two different ways may highlight 
differences in initiation kinetics between cycling cells (centrifugal elutriation of an 
asynchronous population) and cells that are re-entering the cell cycle from G0. G0 cells have 
differences to cycling cells, origins are no longer licence with reductions in CDC6 and MCM 
proteins (Blow & Hodgson, 2002). It would be interesting to see any difference in initiation 




5.7 Future Work 
5.7.1 Cell-free Combing Experiments Resulted in Short Fragmented DNA 
The work done here to attempt to combine the post quiescence release in vitro replication 
system with DNA combing needs further development. Whilst DNA was combed onto a 
silanised coverslip surface it was short and fragmented, furthermore no labelled replication 
tracks could be detected. Further work should be done to modify the system to ensure longer 
strands of DNA, and labelling and detection methods should be modified. Greater fibre length 
would allow for analysis of replication fork speed and IOD. 
The short fragmented DNA is likely due ssDNA nicks being introduced during preparation of 
the genomic DNA, nicks relatively close to each other in opposite strands of DNA will cause 
DNA to be pulled apart during the combing process, creating stretches of fragmented DNA. 
Introducing a higher frequency of nicks will lead to shorter more fragmented DNA (Kaykov et 
al., 2016). Clearly, there was significant DNA damage caused at some point when preparing 
nuclei. Damage caused during the DNA purification process was discussed earlier but briefly, it 
can be minimised by reducing movement and increasing combing speeds. DNA damage could 
have been induced during preparation, for example during the high forces during 
centrifugation. Alternatively, DNA from isolated nuclei could have been damaged during 
storage. They are stored in liquid nitrogen, so by the time they are used experimentally they 
will have passed through a freeze thaw cycle which could damage DNA.  
To test if nuclei isolated from post-quiescent NIH3T3 cells have an increased number of ssDNA 
breaks a number of methods could be used: one such method is a comet assay, comet assays 
are used to measure ssDNA damage. Briefly, cells are lysed in agarose followed by being 
subjected to an electrical current. Damaged DNA migrates further so DNA damage can be 
measured by the length of DNA tails (Olive & Banáth, 2006). This assay could be modified to 
measure if nuclei have large amounts of ssDNA damage. 
5.7.2 Further Work With Ciz1  
Once in vitro replication assays and DNA combing have been successfully combined 
replication kinetics at abnormal cyclin A/CDK2 concentrations should be investigated. If Ciz1 is 
allowing replication to continue in a dysregulated CDK activity high replication stress 
environment (Figure 3.12) then this should be measurable using changes in fork rate, IOD and 
increased replication fork stalling. These factors are all measurable by DNA combing. This 
would provide an important insight into how Ciz1 promotes tumour growth.  
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In order to further investigate Ciz1’s role in DNA replication models should be generated in 
which ciz1 activity is abnormal. One way to achieve this would be through genetic 
manipulation. Ciz1 could be mutated to be made inactive, mutated to change its activity e.g. 
phosphorylation sites, knocked out or be expressed through a different promoter to induce 
Ciz1 overexpression. Data acquired from abnormal Ciz1 activity may help to explain Ciz1 
activity in DNA replication initiation and elongation 
Genetic manipulation with CRISPR/Cas9 provides a powerful tool for modifying genomes of 
mammalian cells. This revolutionary method enables the modification of the genome of cells 
at a high efficiency (Cong et al., 2013). Crispr/Cas9 can be used to insert random mutations in 
an attempt to prevent gene function through DNA repair by NHEJ or precise point mutations 
by transfecting cells with homologous DNA sequence with the desired modified sequence 
(Doudna & Charpentier, 2014).  
Using crispr cas9 NIH3T3 cells expressing CIZ1 could be modified. CRISPR/Cas9 could be used 
to generated Ciz1 knockout NIH3T3 cells. Ciz1 knockout cells generated though CRISPR/Cas9 
gene editing will likely be viable as previously generated Ciz1 knockout mice grew normally 
(Nishibe et al., 2013). This indicated Ciz1 knockouts should be non-lethal and suggest that 
CRISPR-Cas9 deleted cell lines would provide a good model for investigating Ciz1’s role in DNA 
replication in cell-based experiments.  
Once mouse embryonic fibroblast Ciz1 knockouts are generated, the effect of loss of Ciz1 
activity could be measured in a variety of ways: cell proliferation can be measured, changes in 
cell cycle profile could be measured by flow cytometry to determine the portion of cells that 
are in S phase. The ability of cells to synchronously release into S phase from G0 could also be 
measured using the synchronisation techniques discussed earlier, if there are any effects it 
could be measured whether or not they could be rescued by transfection with an expression 
plasmid containing the Ciz1 gene.  
Replication competent nuclei could also be harvested from these cells providing a platform for 
measuring replication dynamics. Replication dynamics of normally cycling could also be 
measure using DNA combing and compared to Ciz1 knockout cells. Parameters that could be 
measured include replication fork velocity and if the DNA purification protocol can be refined 
to stretch longer strands of DNA, inter origin distance and replication fork asymmetry. 
Knockout Ciz1 cells have displayed an increased tumorigenesis in response to DNA damaging 
agents (Nishibe et al., 2013). It is worth investigating if this phenotype would be true of 
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knockout cells generated by CRISPR/Cas9, this will be tested by treatment with DNA damaging 
agents such as hydroxyurea or aphidicolin. Changes in cell proliferation and cell invasiveness 
could be measures and replication dynamics after treatment could be quantified using DNA 
combing. This may help to explain how Ciz1 appears to have both a tumour suppressor and 
oncogenic function.  
Ciz1 knockout cells should also be used to measure changes in cellular replication. Ciz1 
appears to function to promote cells entering S phase through co-ordination of cyclin E and 
cyclin A/CDK2 during the G1/S transition as proposed (Copeland et al., 2010). Knocking out this 
function may have an observable effect on cell cycle profiles using flow cytometric techniques. 
The DNA content of a population of cells can be measured using propidium iodide as a marker 
for DNA content. This then displays the proportion of cells in each phase of the cell cycle. Any 
change seen in the cell cycle profile in ciz1 knock out for example and increase in the G0/G1 
population could be indicative of Ciz1s role. If a change is seen, it should be determined 
whether this can be rescued by transfection with a Ciz1 expression plasmid. 
To add to results that could be gained from generating Ciz1 knockouts using CRISPR/Cas9 
experiments should be done utilizing RNA interference to knock down Ciz1 and cyclin levels to 
investigate the interplay between these factors during DNA replication initiation as well as 
during ongoing DNA replication. Combining Crispr/Cas9 work with other genetic silencing 
techniques such as RNA interference will could provide a diverse set of evidence into the role 
of Ciz1s co-operation with cyclin/CDKs during the G1/S transition and whether alteration of 
this confers a replication stress phenotype. 
5.8 Concluding Remarks  
DNA Combing and in vitro replication assays are powerful tools for investigating DNA 
replication during both the initiation and elongation stages. Further refinements to both 
techniques including new methods and adapting existing methods for acquiring replication 
nuclei could improve both the quantifiable data and the reproducibility of this techniques. 
Further adaptation of the post-quiescent release method for nuclei isolation to couple with 
DNA combing.  
Further work should be done to investigate whether Ap4a inhibits DNA replication in vivo. The 
mechanism by which Ap4a inhibits DNA replication in in vitro replication experiments should 
also be investigated, it should be determined whether or not this is through a novel 
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